Id,Name,Type,VectorableProperty
2,HOMAIR,Phenotype,HOMAIR
19,HDL,Phenotype,HDL
22,Homair Adj Bmi,Phenotype,Homair Adj Bmi
29,Fasting Blood Glucose,Phenotype,Fasting Blood Glucose
59,T2D,Phenotype,T2D
65,Insulin Fold Change Adj Bmi,Phenotype,Insulin Fold Change Adj Bmi
68,BMI,Phenotype,BMI
72,LDL,Phenotype,LDL
77,Fasting Blood Insulin,Phenotype,Fasting Blood Insulin
200,Schizophrenia,Phenotype,Schizophrenia
671,T2D 2024,Phenotype,T2D 2024
950,Glutamine Fructose-6-Phosphate Amidotransferase Adj Bmi,Phenotype,Glutamine Fructose-6-Phosphate Amidotransferase Adj Bmi
1164,Handedness,Phenotype,Handedness
1239,T1D,Phenotype,T1D
1479,Insulin Sensitivity Index Adj Bmi,Phenotype,Insulin Sensitivity Index Adj Bmi
1603,vatAsatRatio,Phenotype,vatAsatRatio
1680,HbA1c,Phenotype,HbA1c
1682,FastingInsulin,Phenotype,FastingInsulin
1709,Coronary Artery Disease,Phenotype,Coronary Artery Disease
2193,Abdominal Subcutaneous Adipose Tissue Adj Bmi,Phenotype,Abdominal Subcutaneous Adipose Tissue Adj Bmi
2326,Waist-Hip Ratio Adj Bmi,Phenotype,Waist-Hip Ratio Adj Bmi
2327,VATadjBMI,Phenotype,VATadjBMI
2331,Proinsulin,Phenotype,Proinsulin
2332,SHBG_LpA,Phenotype,SHBG_LpA
2333,Beta_Cell_2,Phenotype,Beta_Cell_2
2334,Obesity,Phenotype,Obesity
2335,Lipodystrophy_1,Phenotype,Lipodystrophy_1
2336,Bilirubin,Phenotype,Bilirubin
2337,Liver_Lipid,Phenotype,Liver_Lipid
2338,Lipodystrophy_2,Phenotype,Lipodystrophy_2
2339,Hyper_Insulin,Phenotype,Hyper_Insulin
2340,ALP_Neg,Phenotype,ALP_Neg
2341,Total Cholesterol,Phenotype,Total Cholesterol
2342,Beta_Cell_1,Phenotype,Beta_Cell_1
3595,Type 2 Diabetes Mellitus,Phenotype,Type 2 Diabetes Mellitus
5273,Fasting Glucose Magic,Phenotype,Fasting Glucose Magic
5764,Hba1C Magic,Phenotype,Hba1C Magic
6204,Glutamine Fructose-6-Phosphate Amidotransferase (Gfat),Phenotype,Glutamine Fructose-6-Phosphate Amidotransferase (Gfat)
11899,Fasting Insulin Magic,Phenotype,Fasting Insulin Magic
12450,Hba1C Hm3,Phenotype,Hba1C Hm3
12701,Type 1 Diabetes Mellitus,Phenotype,Type 1 Diabetes Mellitus
15974,Urate Levels,Phenotype,Urate Levels
15976,Triglyceride To Hdl Cholesterol Ratio,Phenotype,Triglyceride To Hdl Cholesterol Ratio
15978,Sex Hormone-Binding Globulin Levels Adjusted For Bmi,Phenotype,Sex Hormone-Binding Globulin Levels Adjusted For Bmi
15980,Height,Phenotype,Height
15982,Total Esterified Cholesterol Levels,Phenotype,Total Esterified Cholesterol Levels
15986,Testasv_38 (Ruminococcus) Abundance,Phenotype,Testasv_38 (Ruminococcus) Abundance
15988,Subclinical Hypothyroidism In Pregnancy,Phenotype,Subclinical Hypothyroidism In Pregnancy
15990,Electrocardiogram Morphology (Amplitude At Temporal Datapoints),Phenotype,Electrocardiogram Morphology (Amplitude At Temporal Datapoints)
15993,Non-Hdl Cholesterol Levels,Phenotype,Non-Hdl Cholesterol Levels
15996,Atrial Fibrillation,Phenotype,Atrial Fibrillation
15999,Low Density Lipoprotein Cholesterol Levels,Phenotype,Low Density Lipoprotein Cholesterol Levels
16001,Phospholipid Levels In Medium Vldl,Phenotype,Phospholipid Levels In Medium Vldl
16004,Phospholipids To Total Lipids Ratio In Very Large Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Very Large Hdl
16006,Breast Cancer,Phenotype,Breast Cancer
16008,Coenzyme Q10 Levels,Phenotype,Coenzyme Q10 Levels
16010,Anxiety Severity X Playing Computer Games Interaction,Phenotype,Anxiety Severity X Playing Computer Games Interaction
16012,Hematocrit,Phenotype,Hematocrit
16016,Systolic Blood Pressure,Phenotype,Systolic Blood Pressure
16018,Sarcalumenin Levels,Phenotype,Sarcalumenin Levels
16021,Appendicular Lean Mass,Phenotype,Appendicular Lean Mass
16025,Memory Decline In Impaired Cognition X Sex Interaction,Phenotype,Memory Decline In Impaired Cognition X Sex Interaction
16027,Bone Mineral Density Mean,Phenotype,Bone Mineral Density Mean
16029,F-Acquired Taste Liking (Derived Food-Liking Factor),Phenotype,F-Acquired Taste Liking (Derived Food-Liking Factor)
16031,Glycine Levels,Phenotype,Glycine Levels
16034,Medication Use (Thyroid Preparations),Phenotype,Medication Use (Thyroid Preparations)
16036,Waist-To-Hip Ratio Adjusted For Bmi,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi
16038,Amyotrophic Lateral Sclerosis (Sporadic),Phenotype,Amyotrophic Lateral Sclerosis (Sporadic)
16040,Facial Morphology (Factor 2-- Vertical Position Of Orbits Relative To Midface),Phenotype,Facial Morphology (Factor 2-- Vertical Position Of Orbits Relative To Midface)
16042,Smoking Initiation,Phenotype,Smoking Initiation
16047,Brainstem Volume,Phenotype,Brainstem Volume
16049,Peptidyl-Glycine Alpha-Amidating Monooxygenase Levels (Pam.5620.13.3),Phenotype,Peptidyl-Glycine Alpha-Amidating Monooxygenase Levels (Pam.5620.13.3)
16051,Wg Lh Intensity-Contrast Rostralmiddlefrontal,Phenotype,Wg Lh Intensity-Contrast Rostralmiddlefrontal
16053,Kifbp/Lyn Protein Level Ratio,Phenotype,Kifbp/Lyn Protein Level Ratio
16055,Concentration Of Small Vldl Particles,Phenotype,Concentration Of Small Vldl Particles
16057,Total Phf-Tau (Snp X Snp Interaction),Phenotype,Total Phf-Tau (Snp X Snp Interaction)
16059,Hypertension (Confirmatory Factor Analysis Factor 12),Phenotype,Hypertension (Confirmatory Factor Analysis Factor 12)
16062,Blood Protein Levels,Phenotype,Blood Protein Levels
16064,Migraine Or Glucose Levels,Phenotype,Migraine Or Glucose Levels
16066,Protein Levels In Obesity,Phenotype,Protein Levels In Obesity
16069,Mean Arterial Pressure,Phenotype,Mean Arterial Pressure
16071,Pancreatic Triacylglycerol Lipase Levels,Phenotype,Pancreatic Triacylglycerol Lipase Levels
16073,Peak Height Velocity,Phenotype,Peak Height Velocity
16075,Ascending Aorta Distensibility,Phenotype,Ascending Aorta Distensibility
16078,Liver Enzyme Levels (Alkaline Phosphatase),Phenotype,Liver Enzyme Levels (Alkaline Phosphatase)
16080,Highest Math Class Taken (Mtag),Phenotype,Highest Math Class Taken (Mtag)
16082,Otu99_108 (Cytophagales) Prevalence,Phenotype,Otu99_108 (Cytophagales) Prevalence
16084,Mean Corpuscular Volume,Phenotype,Mean Corpuscular Volume
16088,Educational Attainment,Phenotype,Educational Attainment
16092,Hemoglobin Levels,Phenotype,Hemoglobin Levels
16094,Apolipoprotein B Levels,Phenotype,Apolipoprotein B Levels
16096,Total Lipid Levels In Ldl,Phenotype,Total Lipid Levels In Ldl
16099,Cerebrospinal Fluid Biomarker Levels,Phenotype,Cerebrospinal Fluid Biomarker Levels
16103,Platelet Count,Phenotype,Platelet Count
16105,Lymphocyte Percentage Of White Cells,Phenotype,Lymphocyte Percentage Of White Cells
16107,Triglyceride Levels,Phenotype,Triglyceride Levels
16109,Core Binding Factor Acute Myeloid Leukemia,Phenotype,Core Binding Factor Acute Myeloid Leukemia
16111,Cholesteryl Esters To Total Lipids Ratio In Medium Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Vldl
16114,Red Cell Distribution Width,Phenotype,Red Cell Distribution Width
16116,Phospholipid Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Phospholipid Levels In Chylomicrons And Extremely Large Vldl
16118,Breast Cancer And/Or Colorectal Cancer,Phenotype,Breast Cancer And/Or Colorectal Cancer
16120,Medication Use (Drugs Used In Diabetes),Phenotype,Medication Use (Drugs Used In Diabetes)
16123,Red Blood Cell Count,Phenotype,Red Blood Cell Count
16125,Ulcerative Colitis,Phenotype,Ulcerative Colitis
16127,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy),Phenotype,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy)
16129,Estimated Glomerular Filtration Rate (Cystatin C),Phenotype,Estimated Glomerular Filtration Rate (Cystatin C)
16132,Estimated Glomerular Filtration Rate After 1 Year In Renal Transplantation (Donor Effect),Phenotype,Estimated Glomerular Filtration Rate After 1 Year In Renal Transplantation (Donor Effect)
16134,Mean Platelet Volume,Phenotype,Mean Platelet Volume
16138,Trail Levels,Phenotype,Trail Levels
16140,Cholesterol To Total Lipids Ratio In Medium Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Medium Vldl
16143,Vertical Cup-Disc Ratio,Phenotype,Vertical Cup-Disc Ratio
16147,Body Mass Index (Mtag),Phenotype,Body Mass Index (Mtag)
16151,Anorexia Nervosa-- Attention-Deficit/Hyperactivity Disorder-- Autism Spectrum Disorder-- Bipolar Disorder-- Major Depression-- Obsessive-Compulsive Disorder-- Schizophrenia-- Or Tourette Syndrome (Pleiotropy),Phenotype,Anorexia Nervosa-- Attention-Deficit/Hyperactivity Disorder-- Autism Spectrum Disorder-- Bipolar Disorder-- Major Depression-- Obsessive-Compulsive Disorder-- Schizophrenia-- Or Tourette Syndrome (Pleiotropy)
16153,Lung Adenocarcinoma,Phenotype,Lung Adenocarcinoma
16156,Pulse Pressure,Phenotype,Pulse Pressure
16158,Adult Body Size,Phenotype,Adult Body Size
16160,Small Cell Lung Carcinoma,Phenotype,Small Cell Lung Carcinoma
16162,Migraine Without Aura,Phenotype,Migraine Without Aura
16165,Protein S100-A4 Levels (S100A4.14116.129.3),Phenotype,Protein S100-A4 Levels (S100A4.14116.129.3)
16168,Triglycerides,Phenotype,Triglycerides
16171,Waist-To-Hip Ratio Adjusted For Body Mass Index,Phenotype,Waist-To-Hip Ratio Adjusted For Body Mass Index
16173,Wg Rh Intensity-Contrast Rostralanteriorcingulate,Phenotype,Wg Rh Intensity-Contrast Rostralanteriorcingulate
16175,Basal Cell Carcinoma,Phenotype,Basal Cell Carcinoma
16177,Protein Quantitative Trait Loci (Liver),Phenotype,Protein Quantitative Trait Loci (Liver)
16179,Cerebellin-4 Levels,Phenotype,Cerebellin-4 Levels
16181,Low Tan Response,Phenotype,Low Tan Response
16183,Fat-Free Mass,Phenotype,Fat-Free Mass
16188,Myocardial Infarction,Phenotype,Myocardial Infarction
16190,High Density Lipoprotein Cholesterol Levels,Phenotype,High Density Lipoprotein Cholesterol Levels
16192,Folate Pathway Vitamin Levels,Phenotype,Folate Pathway Vitamin Levels
16194,Inflammatory Bowel Disease,Phenotype,Inflammatory Bowel Disease
16197,Cholesteryl Esters To Total Lipids Ratio In Idl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Idl
16200,Age At First Sexual Intercourse,Phenotype,Age At First Sexual Intercourse
16203,Cholesteryl Ester Levels In Very Large Hdl,Phenotype,Cholesteryl Ester Levels In Very Large Hdl
16206,Melanoma,Phenotype,Melanoma
16208,Diastolic Blood Pressure (Mtag),Phenotype,Diastolic Blood Pressure (Mtag)
16210,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test)
16212,Multiple Sclerosis,Phenotype,Multiple Sclerosis
16216,Dementia With Lewy Bodies In Apoe E4- Carriers,Phenotype,Dementia With Lewy Bodies In Apoe E4- Carriers
16218,Cigarette Consumption X Hours Spent Using Computers Interaction,Phenotype,Cigarette Consumption X Hours Spent Using Computers Interaction
16220,Calcium Levels,Phenotype,Calcium Levels
16222,Body Fat Percentage,Phenotype,Body Fat Percentage
16224,Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ Levels
16226,Triglyceride Levels In Ldl,Phenotype,Triglyceride Levels In Ldl
16228,Psp94 Plasma Levels,Phenotype,Psp94 Plasma Levels
16230,Vaginal Microbiome Metacyc Pathway (Pwy-6562|Norspermidine Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6562|Norspermidine Biosynthesis)
16232,Primary Biliary Cholangitis,Phenotype,Primary Biliary Cholangitis
16234,Waist Circumference Adjusted For Body Mass Index,Phenotype,Waist Circumference Adjusted For Body Mass Index
16236,Central Nucleus Volume,Phenotype,Central Nucleus Volume
16238,Dab2/Tbl1X Protein Level Ratio,Phenotype,Dab2/Tbl1X Protein Level Ratio
16241,Severe Covid-19 Infection,Phenotype,Severe Covid-19 Infection
16246,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid)
16248,Ccl5/Ccn2 Protein Level Ratio,Phenotype,Ccl5/Ccn2 Protein Level Ratio
16250,Coronary Artery Disease (Mtag),Phenotype,Coronary Artery Disease (Mtag)
16252,Phospholipids To Total Lipids Ratio In Medium Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Medium Hdl
16256,Vertex-Wise Cortical Thickness,Phenotype,Vertex-Wise Cortical Thickness
16259,Platelet Count During  First Trimester Of Pregnancy,Phenotype,Platelet Count During  First Trimester Of Pregnancy
16261,Hexanoylcarnitine Levels,Phenotype,Hexanoylcarnitine Levels
16263,Complement Factor H Levels,Phenotype,Complement Factor H Levels
16265,Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+Nh4]1+ Levels
16269,Hdl Cholesterol,Phenotype,Hdl Cholesterol
16271,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test)
16273,Insomnia,Phenotype,Insomnia
16276,Short Sleep Duration (<5 Hours),Phenotype,Short Sleep Duration (<5 Hours)
16279,Thyroid Stimulating Hormone Levels,Phenotype,Thyroid Stimulating Hormone Levels
16281,Serum Metabolite Levels,Phenotype,Serum Metabolite Levels
16283,Gamma Glutamyl Transferase Levels,Phenotype,Gamma Glutamyl Transferase Levels
16285,Lung Cancer (Snp X Snp Interaction),Phenotype,Lung Cancer (Snp X Snp Interaction)
16287,Heel Bone Mineral Density,Phenotype,Heel Bone Mineral Density
16290,Nickel Levels,Phenotype,Nickel Levels
16292,Predicted Visceral Adipose Tissue,Phenotype,Predicted Visceral Adipose Tissue
16295,Phospholipids To Total Lipids Ratio In Small Ldl,Phenotype,Phospholipids To Total Lipids Ratio In Small Ldl
16297,Triacylglycerol(52:4)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(52:4)_[M+Nh4]1+ Levels
16301,Sulfatase-Modifying Factor 2 Levels,Phenotype,Sulfatase-Modifying Factor 2 Levels
16304,Phosphatidylglycerol (36:2) Levels,Phenotype,Phosphatidylglycerol (36:2) Levels
16306,Alcohol Dehydrogenase [Nadp(+)] Levels,Phenotype,Alcohol Dehydrogenase [Nadp(+)] Levels
16308,Ascending Aorta Diameter,Phenotype,Ascending Aorta Diameter
16310,High Light Scatter Reticulocyte Percentage Of Red Cells,Phenotype,High Light Scatter Reticulocyte Percentage Of Red Cells
16312,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ Levels,Phenotype,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ Levels
16314,Obesity-Related Traits,Phenotype,Obesity-Related Traits
16316,Cortical Surface Area (Mostest),Phenotype,Cortical Surface Area (Mostest)
16318,Diastolic Blood Pressure,Phenotype,Diastolic Blood Pressure
16320,Hip Circumference Adjusted For Bmi,Phenotype,Hip Circumference Adjusted For Bmi
16322,C-Reactive Protein,Phenotype,C-Reactive Protein
16324,Neutrophil Count,Phenotype,Neutrophil Count
16326,Ldl Cholesterol,Phenotype,Ldl Cholesterol
16328,Post Bronchodilator Fev1/Fvc Ratio,Phenotype,Post Bronchodilator Fev1/Fvc Ratio
16330,Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+Nh4]1+ Levels
16332,Phosphatidylethanolamine_38:4_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine_38:4_[M-H]1- Levels
16334,Free Cholesterol Levels In Very Large Vldl,Phenotype,Free Cholesterol Levels In Very Large Vldl
16336,Lysophosphatidylcholine(20:4)_[M+H]1+ Levels,Phenotype,Lysophosphatidylcholine(20:4)_[M+H]1+ Levels
16338,Cholesterol_[M+H-H2O]1+ Levels,Phenotype,Cholesterol_[M+H-H2O]1+ Levels
16340,Age At Menopause,Phenotype,Age At Menopause
16343,Spatial Qrs-T Angle,Phenotype,Spatial Qrs-T Angle
16345,Triglycerides To Phosphoglycerides Ratio (Ukb Data Field 23435),Phenotype,Triglycerides To Phosphoglycerides Ratio (Ukb Data Field 23435)
16347,Keratoconus,Phenotype,Keratoconus
16350,Serum Levels Of Protein Cd244,Phenotype,Serum Levels Of Protein Cd244
16353,Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ Levels
16355,Non-Del(5Q) Myelodysplastic Syndromes,Phenotype,Non-Del(5Q) Myelodysplastic Syndromes
16357,White Blood Cell Count,Phenotype,White Blood Cell Count
16359,Total Cholesterol Levels,Phenotype,Total Cholesterol Levels
16361,Body Mass Index In Physically Active Individuals,Phenotype,Body Mass Index In Physically Active Individuals
16363,Triglycerides In Medium Hdl (Ukb Data Field 23571),Phenotype,Triglycerides In Medium Hdl (Ukb Data Field 23571)
16367,Light Vs. Dark Hair Color,Phenotype,Light Vs. Dark Hair Color
16369,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
16372,Schizophrenia (Mtag),Phenotype,Schizophrenia (Mtag)
16376,A Body Shape Index,Phenotype,A Body Shape Index
16378,Phosphatidylethanolamine (16:0_18:2) Levels,Phenotype,Phosphatidylethanolamine (16:0_18:2) Levels
16381,Triacylglycerol_56:7_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol_56:7_[M+Nh4]1+ Levels
16383,Asthma,Phenotype,Asthma
16385,Thromboembolic Events In Sickle Cell Disease,Phenotype,Thromboembolic Events In Sickle Cell Disease
16387,Serum Urate Levels,Phenotype,Serum Urate Levels
16389,Idp Dmri Probtrackx Od Slf R,Phenotype,Idp Dmri Probtrackx Od Slf R
16391,Interleukin-1 Alpha Levels,Phenotype,Interleukin-1 Alpha Levels
16393,Corneal Resistance Factor,Phenotype,Corneal Resistance Factor
16395,Cholesterol Levels In Small Ldl,Phenotype,Cholesterol Levels In Small Ldl
16397,Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ Levels
16400,Idp T1 First Left Pallidum Volume,Phenotype,Idp T1 First Left Pallidum Volume
16402,Fasting Glucose,Phenotype,Fasting Glucose
16404,Crohn'S Disease,Phenotype,Crohn'S Disease
16406,Metabolic Syndrome,Phenotype,Metabolic Syndrome
16408,Neutral And Basic Amino Acid Transport Protein Rbat Levels,Phenotype,Neutral And Basic Amino Acid Transport Protein Rbat Levels
16411,Loneliness,Phenotype,Loneliness
16415,Urate Levels In Overweight Individuals,Phenotype,Urate Levels In Overweight Individuals
16419,Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+Nh4]1+ Levels
16421,Subcortical Volume (Mostest),Phenotype,Subcortical Volume (Mostest)
16423,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test)
16425,Hdl Cholesterol Levels In Current Drinkers,Phenotype,Hdl Cholesterol Levels In Current Drinkers
16427,Epididymal-Specific Lipocalin-8 Levels,Phenotype,Epididymal-Specific Lipocalin-8 Levels
16430,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
16432,Cholesterol Esters In Very Large Hdl,Phenotype,Cholesterol Esters In Very Large Hdl
16434,Neuroticism General Factor,Phenotype,Neuroticism General Factor
16436,Eosinophil Counts,Phenotype,Eosinophil Counts
16438,Multi-Trait Sum Score,Phenotype,Multi-Trait Sum Score
16440,Nonsyndromic Cleft Palate,Phenotype,Nonsyndromic Cleft Palate
16443,Cholesteryl Esters To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
16446,Type 1 Diabetes,Phenotype,Type 1 Diabetes
16448,Eotaxin Level In Chronic Kidney Disease With Hypertension And No Diabetes (5301_7),Phenotype,Eotaxin Level In Chronic Kidney Disease With Hypertension And No Diabetes (5301_7)
16450,Vaginal Microbiome Metacyc Pathway (Teichoicacid-Pwy|Teichoic Acid (Poly-Glycerol) Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Teichoicacid-Pwy|Teichoic Acid (Poly-Glycerol) Biosynthesis)
16452,Peak Expiratory Flow,Phenotype,Peak Expiratory Flow
16455,Contrast Sensitivity,Phenotype,Contrast Sensitivity
16457,Type 2 Diabetes,Phenotype,Type 2 Diabetes
16459,Nonsyndromic Cleft Lip With Cleft Palate,Phenotype,Nonsyndromic Cleft Lip With Cleft Palate
16461,Worry,Phenotype,Worry
16463,Dna Methylation-Estimated Plasminogen Activator Inhibitor-1 Levels,Phenotype,Dna Methylation-Estimated Plasminogen Activator Inhibitor-1 Levels
16466,Apolipoprotein A1 Levels,Phenotype,Apolipoprotein A1 Levels
16468,Ssc-A On Hla Dr+ Natural Killer,Phenotype,Ssc-A On Hla Dr+ Natural Killer
16470,Qt Interval,Phenotype,Qt Interval
16474,Cognitive Ability-- Years Of Educational Attainment Or Schizophrenia (Pleiotropy),Phenotype,Cognitive Ability-- Years Of Educational Attainment Or Schizophrenia (Pleiotropy)
16476,Phosphatidylethanolamine (18:1_18:2) Levels,Phenotype,Phosphatidylethanolamine (18:1_18:2) Levels
16479,Resilience Score,Phenotype,Resilience Score
16482,Sex Hormone-Binding Globulin Levels,Phenotype,Sex Hormone-Binding Globulin Levels
16486,Laryngeal Squamous Cell Carcinoma,Phenotype,Laryngeal Squamous Cell Carcinoma
16488,Left-handedness,Phenotype,Left-handedness
16491,Diacylglycerol(36:3)_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol(36:3)_[M+H-H2O]1+ Levels
16494,Retinal Detachment Or Retinal Break,Phenotype,Retinal Detachment Or Retinal Break
16496,Myopia,Phenotype,Myopia
16501,Phosphatidylcholines (36:4)B Levels,Phenotype,Phosphatidylcholines (36:4)B Levels
16503,Vaginal Microbiome Metacyc Pathway (Pwy-6397|Mycolyl-Arabinogalactan-Peptidoglycan Complex Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6397|Mycolyl-Arabinogalactan-Peptidoglycan Complex Biosynthesis)
16505,Lung Function (Fvc),Phenotype,Lung Function (Fvc)
16507,Metabolite Peak Levels (Qi10664),Phenotype,Metabolite Peak Levels (Qi10664)
16510,Jt Interval,Phenotype,Jt Interval
16513,Mean Corpuscular Hemoglobin,Phenotype,Mean Corpuscular Hemoglobin
16516,Lymphocyte Count,Phenotype,Lymphocyte Count
16518,Alcohol Consumption (Drinks Per Week) (Mtag),Phenotype,Alcohol Consumption (Drinks Per Week) (Mtag)
16521,Educational Attainment (Years Of Education),Phenotype,Educational Attainment (Years Of Education)
16523,Leprosy,Phenotype,Leprosy
16527,Triglycerides To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23583),Phenotype,Triglycerides To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23583)
16529,Creatinine Levels,Phenotype,Creatinine Levels
16531,Depression,Phenotype,Depression
16538,F-Oily Fish Liking (Derived Food-Liking Factor),Phenotype,F-Oily Fish Liking (Derived Food-Liking Factor)
16540,Malaria,Phenotype,Malaria
16542,Homa-B (Corrected For Homa-Ir),Phenotype,Homa-B (Corrected For Homa-Ir)
16544,Asthma Or Allergic Disease (Pleiotropy),Phenotype,Asthma Or Allergic Disease (Pleiotropy)
16546,Neuroticism,Phenotype,Neuroticism
16549,Rheumatoid Arthritis,Phenotype,Rheumatoid Arthritis
16551,Self-Reported Math Ability,Phenotype,Self-Reported Math Ability
16553,Body Mass Index X Other Green Vegetables (Green Pepper And Green Beans) Consumption Interaction,Phenotype,Body Mass Index X Other Green Vegetables (Green Pepper And Green Beans) Consumption Interaction
16556,Major Depressive Disorder,Phenotype,Major Depressive Disorder
16558,Interleukin-1 Receptor-Associated Kinase 4 Levels,Phenotype,Interleukin-1 Receptor-Associated Kinase 4 Levels
16560,Bmi And Adiposity (Confirmatory Factor Analysis Factor 7),Phenotype,Bmi And Adiposity (Confirmatory Factor Analysis Factor 7)
16562,Circulating Docosahexaenoic Acid Levels,Phenotype,Circulating Docosahexaenoic Acid Levels
16564,Amygnuclei Lh Volume Lateral-Nucleus,Phenotype,Amygnuclei Lh Volume Lateral-Nucleus
16567,Breast Size,Phenotype,Breast Size
16569,Obesity (Early Onset Extreme),Phenotype,Obesity (Early Onset Extreme)
16571,Hypertension,Phenotype,Hypertension
16573,Whole Body Fat Free Mass (Ukb Data Field 23101),Phenotype,Whole Body Fat Free Mass (Ukb Data Field 23101)
16578,Cd163/Msr1 Protein Level Ratio,Phenotype,Cd163/Msr1 Protein Level Ratio
16580,Prostate-Specific Antigen Levels,Phenotype,Prostate-Specific Antigen Levels
16584,Caffeine Metabolism (Plasma 1--7-Dimethylxanthine (Paraxanthine) To 1--3--7-Trimethylxanthine (Caffeine) Ratio),Phenotype,Caffeine Metabolism (Plasma 1--7-Dimethylxanthine (Paraxanthine) To 1--3--7-Trimethylxanthine (Caffeine) Ratio)
16589,Bioavailable Testosterone Levels,Phenotype,Bioavailable Testosterone Levels
16592,Cerebral Microbleeds,Phenotype,Cerebral Microbleeds
16594,Cervical Cancer,Phenotype,Cervical Cancer
16596,O-Cresol Sulfate Levels In Elite Athletes,Phenotype,O-Cresol Sulfate Levels In Elite Athletes
16598,Waist-Hip Ratio,Phenotype,Waist-Hip Ratio
16600,Plasma X-22162 Levels In Chronic Kidney Disease,Phenotype,Plasma X-22162 Levels In Chronic Kidney Disease
16603,Global Electrical Heterogeneity Phenotypes,Phenotype,Global Electrical Heterogeneity Phenotypes
16605,Memory Decline In Impaired Cognition,Phenotype,Memory Decline In Impaired Cognition
16609,Ornithine Levels,Phenotype,Ornithine Levels
16611,Advanced Age-Related Macular Degeneration,Phenotype,Advanced Age-Related Macular Degeneration
16613,Cholelithiasis (Ukb Data Field 20002_1162),Phenotype,Cholelithiasis (Ukb Data Field 20002_1162)
16616,Fish- And Plant-Related Diet,Phenotype,Fish- And Plant-Related Diet
16618,Breast Cancer (Survival),Phenotype,Breast Cancer (Survival)
16620,Left Colon Colorectal Cancer (Peritoneal Metastasis Vs No Metastasis),Phenotype,Left Colon Colorectal Cancer (Peritoneal Metastasis Vs No Metastasis)
16623,Fasting Plasma Glycodeoxycholate 3-O-Glucuronide Concentration,Phenotype,Fasting Plasma Glycodeoxycholate 3-O-Glucuronide Concentration
16626,Direct Bilirubin Levels,Phenotype,Direct Bilirubin Levels
16628,Diverticular Disease,Phenotype,Diverticular Disease
16630,Pr Interval,Phenotype,Pr Interval
16632,Serum Levels Of Protein Fn1,Phenotype,Serum Levels Of Protein Fn1
16634,Central Corneal Thickness,Phenotype,Central Corneal Thickness
16636,Depressive Symptoms,Phenotype,Depressive Symptoms
16638,Follistatin-Related Protein 3 Levels,Phenotype,Follistatin-Related Protein 3 Levels
16641,Facial Morphology,Phenotype,Facial Morphology
16643,Platelet-To-Lymphocyte Ratio,Phenotype,Platelet-To-Lymphocyte Ratio
16645,Migraine (Mtag),Phenotype,Migraine (Mtag)
16649,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index),Phenotype,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index)
16652,Ldl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Ldl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
16655,Brain Shape (Segment 80),Phenotype,Brain Shape (Segment 80)
16658,Heart Rate Response To Exercise,Phenotype,Heart Rate Response To Exercise
16664,Facial Morphology (Segment 7),Phenotype,Facial Morphology (Segment 7)
16666,O-Sulfo-L-Tyrosine Levels,Phenotype,O-Sulfo-L-Tyrosine Levels
16668,Cognitive Performance (Mtag),Phenotype,Cognitive Performance (Mtag)
16671,Colec12/Tafa5 Protein Level Ratio,Phenotype,Colec12/Tafa5 Protein Level Ratio
16674,Retinal Arteriolar Tortuosity,Phenotype,Retinal Arteriolar Tortuosity
16676,Reticulocyte Fraction Of Red Cells,Phenotype,Reticulocyte Fraction Of Red Cells
16679,Gut Microbiota Abundance (K_Bacteria.P_Actinobacteria.C_Actinobacteria.O_Bifidobacteriales.F_Bifidobacteriaceae.G_Bifidobacterium.S_Bifidobacterium_Adolescentis),Phenotype,Gut Microbiota Abundance (K_Bacteria.P_Actinobacteria.C_Actinobacteria.O_Bifidobacteriales.F_Bifidobacteriaceae.G_Bifidobacterium.S_Bifidobacterium_Adolescentis)
16681,General Cognitive Ability,Phenotype,General Cognitive Ability
16683,Total Bilirubin Levels In Hiv-1 Infection,Phenotype,Total Bilirubin Levels In Hiv-1 Infection
16685,Gestational Age At Birth (Child Effect),Phenotype,Gestational Age At Birth (Child Effect)
16687,Methoxychlor Levels,Phenotype,Methoxychlor Levels
16689,Monocyte Count,Phenotype,Monocyte Count
16692,Phospholipid Levels In Very Large Hdl,Phenotype,Phospholipid Levels In Very Large Hdl
16695,Ocular Sarcoidosis In Sarcoidosis,Phenotype,Ocular Sarcoidosis In Sarcoidosis
16698,COVID-19,Phenotype,COVID-19
16702,Glycated Hemoglobin Levels,Phenotype,Glycated Hemoglobin Levels
16704,Alcohol Dependence (Dominant Genetic Model),Phenotype,Alcohol Dependence (Dominant Genetic Model)
16707,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire,Phenotype,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire
16709,Response To Methotrexate In Juvenile Idiopathic Arthritis,Phenotype,Response To Methotrexate In Juvenile Idiopathic Arthritis
16711,Deliberate Self-Harm,Phenotype,Deliberate Self-Harm
16714,Memory Decline,Phenotype,Memory Decline
16716,Neurofibrillary Tangles (Snp X Snp Interaction),Phenotype,Neurofibrillary Tangles (Snp X Snp Interaction)
16721,Cholesteryl Esters To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23621),Phenotype,Cholesteryl Esters To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23621)
16723,Overall Survival In Er Negative Breast Cancer,Phenotype,Overall Survival In Er Negative Breast Cancer
16725,Allergic Disease (Asthma-- Hay Fever And/Or Eczema) (Multivariate Analysis),Phenotype,Allergic Disease (Asthma-- Hay Fever And/Or Eczema) (Multivariate Analysis)
16727,Gall Stone Disease Or Coronary Artery Disease,Phenotype,Gall Stone Disease Or Coronary Artery Disease
16729,1-Margaroyl-2-Linoleoyl-Gpc (17:0/18:2) Levels,Phenotype,1-Margaroyl-2-Linoleoyl-Gpc (17:0/18:2) Levels
16731,Body Mass Index And Coronary Artery Disease (Pairwise),Phenotype,Body Mass Index And Coronary Artery Disease (Pairwise)
16733,Heart Failure,Phenotype,Heart Failure
16740,Interferon-Related Traits,Phenotype,Interferon-Related Traits
16742,Mosquito Bite Size,Phenotype,Mosquito Bite Size
16744,Neutrophils And Lymphocytes In Blood (Confirmatory Factor Analysis Factor 35),Phenotype,Neutrophils And Lymphocytes In Blood (Confirmatory Factor Analysis Factor 35)
16748,Cytochrome P450 3A4 Levels,Phenotype,Cytochrome P450 3A4 Levels
16750,Drinks Per Week,Phenotype,Drinks Per Week
16753,Antipsychotic-Induced Ldl-Cholesterol Change In Schizophrenia (4-Week),Phenotype,Antipsychotic-Induced Ldl-Cholesterol Change In Schizophrenia (4-Week)
16755,Heart Rate In Heart Failure With Reduced Ejection Fraction,Phenotype,Heart Rate In Heart Failure With Reduced Ejection Fraction
16757,Monocyte Forward Scatter Distribution Width,Phenotype,Monocyte Forward Scatter Distribution Width
16759,Blood Urea Nitrogen Levels,Phenotype,Blood Urea Nitrogen Levels
16761,Cold Induced Vasodilation,Phenotype,Cold Induced Vasodilation
16763,Asthma (Childhood Onset),Phenotype,Asthma (Childhood Onset)
16765,Seropositivity For Bartonella Henselae Peptide (Agilent_237188),Phenotype,Seropositivity For Bartonella Henselae Peptide (Agilent_237188)
16769,Non-Melanoma Skin Cancer,Phenotype,Non-Melanoma Skin Cancer
16773,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis)
16777,Alzheimer'S Disease Or Educational Attainment (Pleiotropy),Phenotype,Alzheimer'S Disease Or Educational Attainment (Pleiotropy)
16780,Intraocular Pressure (Confirmatory Factor Analysis Factor 26),Phenotype,Intraocular Pressure (Confirmatory Factor Analysis Factor 26)
16782,Household Income (Mtag),Phenotype,Household Income (Mtag)
16784,Seropositivity For Plasmodium Falciparum Peptide (Twist_36885),Phenotype,Seropositivity For Plasmodium Falciparum Peptide (Twist_36885)
16786,Concentration Of Small Ldl Particles,Phenotype,Concentration Of Small Ldl Particles
16790,Ceramide Levels,Phenotype,Ceramide Levels
16792,Fractalkine Levels,Phenotype,Fractalkine Levels
16795,Total Cholesterol In Medium Ldl,Phenotype,Total Cholesterol In Medium Ldl
16799,Protein Delta Homolog 1:Extracellular Domain Levels,Phenotype,Protein Delta Homolog 1:Extracellular Domain Levels
16802,Essential Hypertension (Time To Event),Phenotype,Essential Hypertension (Time To Event)
16804,Color Vision Defects (Deutan-Protan),Phenotype,Color Vision Defects (Deutan-Protan)
16806,Pancreatic Cancer,Phenotype,Pancreatic Cancer
16811,Highest Math Class Taken,Phenotype,Highest Math Class Taken
16814,Resistance To Covid-19 Infection (Exposed Negative Vs Positive),Phenotype,Resistance To Covid-19 Infection (Exposed Negative Vs Positive)
16817,Corneal Curvature,Phenotype,Corneal Curvature
16819,Free Cholesterol In Medium Ldl,Phenotype,Free Cholesterol In Medium Ldl
16825,FVC,Phenotype,FVC
16829,Cholesterol In Small Vldl (Ukb Data Field 23512),Phenotype,Cholesterol In Small Vldl (Ukb Data Field 23512)
16833,Waist-To-Hip Ratio Adjusted For Bmi (Adjusted For Smoking Behaviour),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Adjusted For Smoking Behaviour)
16835,Medication Use (Antihypertensives),Phenotype,Medication Use (Antihypertensives)
16837,Waist-Hip Index,Phenotype,Waist-Hip Index
16838,Basophil Count,Phenotype,Basophil Count
16841,Stable Warfarin Dose,Phenotype,Stable Warfarin Dose
16843,Beans Liking,Phenotype,Beans Liking
16846,Bone Mineral Density,Phenotype,Bone Mineral Density
16848,Dorsomedial Frontal Area (Unadjusted For Global Measures),Phenotype,Dorsomedial Frontal Area (Unadjusted For Global Measures)
16851,Caspase Recruitment Domain-Containing Protein 18 Levels,Phenotype,Caspase Recruitment Domain-Containing Protein 18 Levels
16853,Pcdh17/Ptprm Protein Level Ratio,Phenotype,Pcdh17/Ptprm Protein Level Ratio
16856,Igg Glycosylation,Phenotype,Igg Glycosylation
16859,Educational Attainment (Mtag),Phenotype,Educational Attainment (Mtag)
16861,Verbal Learning,Phenotype,Verbal Learning
16863,Smoking Initiation (Ever Regular Vs Never Regular) (Mtag),Phenotype,Smoking Initiation (Ever Regular Vs Never Regular) (Mtag)
16865,Reticulocyte Count,Phenotype,Reticulocyte Count
16867,5Alpha-Pregnan-3Beta--20Alpha-Diol Monosulfate (2) Levels In Elite Athletes,Phenotype,5Alpha-Pregnan-3Beta--20Alpha-Diol Monosulfate (2) Levels In Elite Athletes
16870,Gestational Thrombocytopenia,Phenotype,Gestational Thrombocytopenia
16873,Trafficking Protein Particle Complex Subunit 4 Levels,Phenotype,Trafficking Protein Particle Complex Subunit 4 Levels
16876,Total Lipids In Medium Vldl,Phenotype,Total Lipids In Medium Vldl
16878,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Physical Activity Interaction),Phenotype,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Physical Activity Interaction)
16880,Triglycerides To Total Lipids Ratio In Large Ldl,Phenotype,Triglycerides To Total Lipids Ratio In Large Ldl
16882,Dementia,Phenotype,Dementia
16884,Covid-19 (Covid Vs Negative),Phenotype,Covid-19 (Covid Vs Negative)
16889,Regular Attendance At A Gym Or Sports Club,Phenotype,Regular Attendance At A Gym Or Sports Club
16892,High Light Scatter Reticulocyte Count,Phenotype,High Light Scatter Reticulocyte Count
16894,Self-Reported Allergy,Phenotype,Self-Reported Allergy
16896,Crisps Liking,Phenotype,Crisps Liking
16898,Venous Thromboembolism (Snp X Snp Interaction),Phenotype,Venous Thromboembolism (Snp X Snp Interaction)
16900,Response To Cognitive-Behavioural Therapy In Anxiety Disorder,Phenotype,Response To Cognitive-Behavioural Therapy In Anxiety Disorder
16904,Platelet Distribution Width,Phenotype,Platelet Distribution Width
16912,Pentraxin-Related Protein Ptx3 Levels,Phenotype,Pentraxin-Related Protein Ptx3 Levels
16915,X-12244--N-Acetylcarnosine Levels,Phenotype,X-12244--N-Acetylcarnosine Levels
16918,Physiological Traits,Phenotype,Physiological Traits
16921,Cannabis Use Disorder,Phenotype,Cannabis Use Disorder
16925,Transcription Initiation Factor Tfiid Subunit 10 Levels,Phenotype,Transcription Initiation Factor Tfiid Subunit 10 Levels
16927,Fasting Insulin Z-Score (>50Th Percentile),Phenotype,Fasting Insulin Z-Score (>50Th Percentile)
16929,Cigarettes Smoked Per Day,Phenotype,Cigarettes Smoked Per Day
16938,Facial Morphology (Segment 14),Phenotype,Facial Morphology (Segment 14)
16941,Suicide Attempts,Phenotype,Suicide Attempts
16945,Pediatric Bone Mineral Content (Radius),Phenotype,Pediatric Bone Mineral Content (Radius)
16947,Triglycerides To Total Lipids In Small Ldl Percentage (Ukb Data Field 23628),Phenotype,Triglycerides To Total Lipids In Small Ldl Percentage (Ukb Data Field 23628)
16949,Femur Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,Femur Bone Mineral Density X Serum Urate Levels Interaction
16954,Acute Radiotoxicity In Prostate Cancer,Phenotype,Acute Radiotoxicity In Prostate Cancer
16956,Shoulder Impingement Syndrome,Phenotype,Shoulder Impingement Syndrome
16959,Post Bronchodilator Fev1,Phenotype,Post Bronchodilator Fev1
16961,Interleukin-17 Receptor D Levels,Phenotype,Interleukin-17 Receptor D Levels
16967,Covid-19 (Hospitalized Vs Not Hospitalized),Phenotype,Covid-19 (Hospitalized Vs Not Hospitalized)
16969,Testosterone Levels X Vegetarianism Interaction,Phenotype,Testosterone Levels X Vegetarianism Interaction
16971,Glucose-Dependent Insulinotropic Peptide Levels,Phenotype,Glucose-Dependent Insulinotropic Peptide Levels
16977,Surgical Knee Osteoarthritis,Phenotype,Surgical Knee Osteoarthritis
16981,Whole Brain Free Water Diffusion (Multivariate Analysis),Phenotype,Whole Brain Free Water Diffusion (Multivariate Analysis)
16983,White Blood Cell Count (Basophil),Phenotype,White Blood Cell Count (Basophil)
16985,Serum Alkaline Phosphatase Levels,Phenotype,Serum Alkaline Phosphatase Levels
16987,Bipolar Disorder,Phenotype,Bipolar Disorder
16989,Optic Disc Size,Phenotype,Optic Disc Size
16991,Body Mass Index (Change Over Time),Phenotype,Body Mass Index (Change Over Time)
16993,Caproate (6:0) Levels,Phenotype,Caproate (6:0) Levels
16996,3-Hydroxyisobutyrate Levels In Elite Athletes,Phenotype,3-Hydroxyisobutyrate Levels In Elite Athletes
16998,Alzheimer'S Disease With Visuospatial Domain Impairment,Phenotype,Alzheimer'S Disease With Visuospatial Domain Impairment
17000,Hdl Cholesterol Levels,Phenotype,Hdl Cholesterol Levels
17003,X-24947 Levels,Phenotype,X-24947 Levels
17006,Response To Metformin (Ic50),Phenotype,Response To Metformin (Ic50)
17008,Leucine-Rich Repeat And Transmembrane Domain-Containing Protein 1 Levels,Phenotype,Leucine-Rich Repeat And Transmembrane Domain-Containing Protein 1 Levels
17010,C-Reactive Protein Levels (Mtag),Phenotype,C-Reactive Protein Levels (Mtag)
17017,Alzheimer'S Disease (Cognitive Decline),Phenotype,Alzheimer'S Disease (Cognitive Decline)
17019,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score),Phenotype,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score)
17023,Osteoarthritis,Phenotype,Osteoarthritis
17024,Deep White Matter Hyperintensities,Phenotype,Deep White Matter Hyperintensities
17026,Plateletcrit,Phenotype,Plateletcrit
17028,Sphingomyelin(32:1)_[M+H]1+ Levels,Phenotype,Sphingomyelin(32:1)_[M+H]1+ Levels
17033,Brain Morphology (Min-P),Phenotype,Brain Morphology (Min-P)
17038,Decanoylcarnitine Levels,Phenotype,Decanoylcarnitine Levels
17043,Response To Hepatitis C Treatment,Phenotype,Response To Hepatitis C Treatment
17045,Ischemic Stroke (Cardioembolic),Phenotype,Ischemic Stroke (Cardioembolic)
17047,Serum Urea Levels,Phenotype,Serum Urea Levels
17049,Migraine,Phenotype,Migraine
17051,Glycosyl Ceramide (D18:1/20:0-- D16:1/22:0) Levels,Phenotype,Glycosyl Ceramide (D18:1/20:0-- D16:1/22:0) Levels
17054,Eosinophil Forward Scatter,Phenotype,Eosinophil Forward Scatter
17056,Endometriosis,Phenotype,Endometriosis
17058,Hemoglobin Concentration,Phenotype,Hemoglobin Concentration
17061,Multimerin-2 Levels (Mmrn2.11895.21.3),Phenotype,Multimerin-2 Levels (Mmrn2.11895.21.3)
17064,Testican-3 Levels,Phenotype,Testican-3 Levels
17066,Brain Volume In Infants (Grey Matter),Phenotype,Brain Volume In Infants (Grey Matter)
17069,Erbin/Lat2 Protein Level Ratio,Phenotype,Erbin/Lat2 Protein Level Ratio
17071,Reticulocyte Side Fluorescence,Phenotype,Reticulocyte Side Fluorescence
17073,Dental Caries,Phenotype,Dental Caries
17076,Protocadherin-10:Extracellular Domain Levels,Phenotype,Protocadherin-10:Extracellular Domain Levels
17078,Chronic Obstructive Pulmonary Disease,Phenotype,Chronic Obstructive Pulmonary Disease
17081,Estimated Glomerular Filtration Rate (Creatinine-- Cystatin C),Phenotype,Estimated Glomerular Filtration Rate (Creatinine-- Cystatin C)
17083,Adolescent Idiopathic Scoliosis,Phenotype,Adolescent Idiopathic Scoliosis
17085,Covid-19 (Critical Illness Vs Population),Phenotype,Covid-19 (Critical Illness Vs Population)
17090,Growth-Regulated Alpha Protein Levels,Phenotype,Growth-Regulated Alpha Protein Levels
17092,Cognitive Performance (Attention) (Longitudinal),Phenotype,Cognitive Performance (Attention) (Longitudinal)
17095,Cortical Thickness,Phenotype,Cortical Thickness
17099,Vitamin D-Binding Protein Levels,Phenotype,Vitamin D-Binding Protein Levels
17101,Allergic Sensitization,Phenotype,Allergic Sensitization
17103,Nk-Cell Telomere Length,Phenotype,Nk-Cell Telomere Length
17105,Estimated Glomerular Filtration Rate,Phenotype,Estimated Glomerular Filtration Rate
17107,Glucose Levels,Phenotype,Glucose Levels
17109,Diffuse Plaques (Snp X Snp Interaction),Phenotype,Diffuse Plaques (Snp X Snp Interaction)
17111,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test)
17112,Venous Thromboembolism,Phenotype,Venous Thromboembolism
17115,Multi-Trait Sex Score,Phenotype,Multi-Trait Sex Score
17118,Personality Traits Or Cognitive Traits (Multivariate Analysis),Phenotype,Personality Traits Or Cognitive Traits (Multivariate Analysis)
17121,Vaginal Microbiome Metacyc Pathway (Pwy0-321|Phenylacetate Degradation I (Aerobic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-321|Phenylacetate Degradation I (Aerobic))
17125,Composite Immunoglobulin Trait (Igg/Igm),Phenotype,Composite Immunoglobulin Trait (Igg/Igm)
17127,Monohexosylceramide (D16:1/18:0) Levels,Phenotype,Monohexosylceramide (D16:1/18:0) Levels
17129,Modified Stumvoll Insulin Sensitivity Index (Bmi Interaction),Phenotype,Modified Stumvoll Insulin Sensitivity Index (Bmi Interaction)
17131,Smooth-Surface Caries,Phenotype,Smooth-Surface Caries
17133,Emphysema Annual Change Measurement In Smokers (Adjusted Lung Density),Phenotype,Emphysema Annual Change Measurement In Smokers (Adjusted Lung Density)
17135,Sterol Ester (27:1/18:2) Levels,Phenotype,Sterol Ester (27:1/18:2) Levels
17138,Rectal Cancer,Phenotype,Rectal Cancer
17140,Uveal Melanoma (Tnm Stage 3 Or 4),Phenotype,Uveal Melanoma (Tnm Stage 3 Or 4)
17142,S-Methylmethionine--Homocysteine S-Methyltransferase Bhmt2 Levels,Phenotype,S-Methylmethionine--Homocysteine S-Methyltransferase Bhmt2 Levels
17146,Enterococcaceae Abundance In Stool,Phenotype,Enterococcaceae Abundance In Stool
17149,Phospholipids In Small Vldl,Phenotype,Phospholipids In Small Vldl
17151,Atrial Fibrillation (Mtag),Phenotype,Atrial Fibrillation (Mtag)
17154,Efna4/Scarb2 Protein Level Ratio,Phenotype,Efna4/Scarb2 Protein Level Ratio
17156,Eczema,Phenotype,Eczema
17158,Blond Vs. Brown/Black Hair Color,Phenotype,Blond Vs. Brown/Black Hair Color
17166,Limited Cutaneous Systemic Scleroderma,Phenotype,Limited Cutaneous Systemic Scleroderma
17168,Cigarettes Smoked Per Day (Mtag),Phenotype,Cigarettes Smoked Per Day (Mtag)
17170,Abdominal Aortic Aneurysm,Phenotype,Abdominal Aortic Aneurysm
17172,Estimated Glomerular Filtration Rate (Creatinine),Phenotype,Estimated Glomerular Filtration Rate (Creatinine)
17176,Systolic Blood Pressure (Bmi Unadjusted),Phenotype,Systolic Blood Pressure (Bmi Unadjusted)
17178,Diisocyanate-Induced Asthma,Phenotype,Diisocyanate-Induced Asthma
17182,Baseline Memory In Impaired Cognition,Phenotype,Baseline Memory In Impaired Cognition
17184,Principal Component-Derived Dietary Pattern 1,Phenotype,Principal Component-Derived Dietary Pattern 1
17187,Urine X-11612 Levels In Chronic Kidney Disease,Phenotype,Urine X-11612 Levels In Chronic Kidney Disease
17190,Aspartate Aminotransferase Levels,Phenotype,Aspartate Aminotransferase Levels
17192,Eosinophil-Derived Neurotoxin Levels,Phenotype,Eosinophil-Derived Neurotoxin Levels
17195,Chronotype,Phenotype,Chronotype
17197,Itgb1Bp2/Tia1 Protein Level Ratio,Phenotype,Itgb1Bp2/Tia1 Protein Level Ratio
17199,Allergy,Phenotype,Allergy
17202,Phosphatidylglycerol(32:1)_[M+Oac]1- Levels,Phenotype,Phosphatidylglycerol(32:1)_[M+Oac]1- Levels
17204,Night Sleep Phenotypes,Phenotype,Night Sleep Phenotypes
17209,Suicide Attempt Severity In Mood Disorders,Phenotype,Suicide Attempt Severity In Mood Disorders
17214,Metabolite Levels,Phenotype,Metabolite Levels
17216,Sphingolipid Levels,Phenotype,Sphingolipid Levels
17219,Endrin Levels,Phenotype,Endrin Levels
17222,Parkinson'S Disease,Phenotype,Parkinson'S Disease
17227,Vwf Levels,Phenotype,Vwf Levels
17230,Cystatin C Levels,Phenotype,Cystatin C Levels
17232,Arachidonoylcarnitine (C20:4) Levels,Phenotype,Arachidonoylcarnitine (C20:4) Levels
17236,Cognitive Decline Rate In Late Mild Cognitive Impairment,Phenotype,Cognitive Decline Rate In Late Mild Cognitive Impairment
17239,Nicotine Dependence,Phenotype,Nicotine Dependence
17241,Blood And Toenail Selenium Levels,Phenotype,Blood And Toenail Selenium Levels
17243,Lysophosphatidylethanolamine (16:0) [Sn1] Levels,Phenotype,Lysophosphatidylethanolamine (16:0) [Sn1] Levels
17245,Hars1/Mesd Protein Level Ratio,Phenotype,Hars1/Mesd Protein Level Ratio
17249,Autism Spectrum Disorder Or Schizophrenia,Phenotype,Autism Spectrum Disorder Or Schizophrenia
17251,Cleft Lip With Or Without Cleft Palate,Phenotype,Cleft Lip With Or Without Cleft Palate
17253,Waist Circumference Adjusted For Bmi In Active Individuals,Phenotype,Waist Circumference Adjusted For Bmi In Active Individuals
17255,Major Depressive Disorder Or Stress-Related Disorder,Phenotype,Major Depressive Disorder Or Stress-Related Disorder
17257,Concentration Of Large Vldl Particles,Phenotype,Concentration Of Large Vldl Particles
17259,Mortality In Sepsis,Phenotype,Mortality In Sepsis
17264,Rs-Warfarin Levels,Phenotype,Rs-Warfarin Levels
17270,Sum Eosinophil Basophil Counts,Phenotype,Sum Eosinophil Basophil Counts
17275,Corneal Astigmatism,Phenotype,Corneal Astigmatism
17277,White Matter Microstructure (Radial Diusivities),Phenotype,White Matter Microstructure (Radial Diusivities)
17283,Cd5/Il16 Protein Level Ratio,Phenotype,Cd5/Il16 Protein Level Ratio
17286,Free Testosterone Levels,Phenotype,Free Testosterone Levels
17288,Risk-Taking Tendency (4-Domain Principal Component Model),Phenotype,Risk-Taking Tendency (4-Domain Principal Component Model)
17295,Leisure Sedentary Behaviour (Television Watching),Phenotype,Leisure Sedentary Behaviour (Television Watching)
17297,Total Testosterone Levels,Phenotype,Total Testosterone Levels
17301,Cortical Surface Area,Phenotype,Cortical Surface Area
17303,Free Cholesterol To Total Lipids Ratio In Small Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Ldl
17305,Hair Color,Phenotype,Hair Color
17307,Post Bronchodilator Fev1/Fvc Ratio In Copd,Phenotype,Post Bronchodilator Fev1/Fvc Ratio In Copd
17310,Prostate Cancer,Phenotype,Prostate Cancer
17312,C-Reactive Protein Levels,Phenotype,C-Reactive Protein Levels
17315,Free Cholesterol To Total Lipids Ratio In Medium Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Medium Ldl
17317,Medication Use For Hypertension (Number Of Purchases),Phenotype,Medication Use For Hypertension (Number Of Purchases)
17319,Renal Function And Chronic Kidney Disease,Phenotype,Renal Function And Chronic Kidney Disease
17324,Proinsulin Levels,Phenotype,Proinsulin Levels
17326,Cortical Thickness (Mostest),Phenotype,Cortical Thickness (Mostest)
17328,Shingles,Phenotype,Shingles
17330,Brain Morphology (Mostest),Phenotype,Brain Morphology (Mostest)
17332,FEV1,Phenotype,FEV1
17334,Inhibitory Control,Phenotype,Inhibitory Control
17336,Systemic Sclerosis,Phenotype,Systemic Sclerosis
17339,Precentral Gyrus Volume,Phenotype,Precentral Gyrus Volume
17345,Body Surface Area,Phenotype,Body Surface Area
17347,Diacylglycerol_38:5_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:5_[M+H-H2O]1+ Levels
17349,Blood Pressure (Pleiotropy Model 2 Sbp Adjusted For Estimated Causal Effects X Dbp),Phenotype,Blood Pressure (Pleiotropy Model 2 Sbp Adjusted For Estimated Causal Effects X Dbp)
17355,Handedness In Dyslexia,Phenotype,Handedness In Dyslexia
17358,Cholesteryl Esters To Total Lipids Ratio In Medium Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Ldl
17360,Free Androgen Index,Phenotype,Free Androgen Index
17363,Essential Tremor,Phenotype,Essential Tremor
17367,Periodontitis (Mean Pal),Phenotype,Periodontitis (Mean Pal)
17369,Concentration Of Very Large Vldl Particles (Ukb Data Field 23488),Phenotype,Concentration Of Very Large Vldl Particles (Ukb Data Field 23488)
17371,Excessive Daytime Sleepiness,Phenotype,Excessive Daytime Sleepiness
17373,Gastric Cancer,Phenotype,Gastric Cancer
17377,Morning Vs. Evening Chronotype,Phenotype,Morning Vs. Evening Chronotype
17380,Alkenylphosphatidylethanolamine (P-20:0/18:2) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-20:0/18:2) Levels
17382,Cd79B/Tnfrsf13B Protein Level Ratio,Phenotype,Cd79B/Tnfrsf13B Protein Level Ratio
17384,Familial Lung Adenocarcinoma,Phenotype,Familial Lung Adenocarcinoma
17386,Atopic Asthma,Phenotype,Atopic Asthma
17388,Cortical Thickness (Min-P),Phenotype,Cortical Thickness (Min-P)
17391,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome,Phenotype,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome
17394,Hip Index,Phenotype,Hip Index
17396,Emotional Lability In Attention Deficit Hyperactivity Disorder,Phenotype,Emotional Lability In Attention Deficit Hyperactivity Disorder
17399,Cholesteryl Esters To Total Lipids Ratio In Small Hdl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Hdl
17401,Vaginal Microbiome Relative Abundance (S_Peptoniphilus Vaginalis),Phenotype,Vaginal Microbiome Relative Abundance (S_Peptoniphilus Vaginalis)
17403,Adverse Response To Inhaled Corticosteroid Treatment X Age Interaction In Asthma,Phenotype,Adverse Response To Inhaled Corticosteroid Treatment X Age Interaction In Asthma
17406,Circulating Chromogranin Peptide Levels,Phenotype,Circulating Chromogranin Peptide Levels
17408,Sunburns,Phenotype,Sunburns
17411,Micb_Mica/Tek Protein Level Ratio,Phenotype,Micb_Mica/Tek Protein Level Ratio
17414,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy)
17419,Alzheimer'S Disease-- Proxy Alzheimer'S Disease Or Related Dementias,Phenotype,Alzheimer'S Disease-- Proxy Alzheimer'S Disease Or Related Dementias
17422,Type 2 Diabetes Or Prostate Cancer (Pleiotropy),Phenotype,Type 2 Diabetes Or Prostate Cancer (Pleiotropy)
17425,Brain Shape (Segment 1),Phenotype,Brain Shape (Segment 1)
17428,Height (Standard Gwa),Phenotype,Height (Standard Gwa)
17434,Type 1 Diabetes (Age At Diagnosis),Phenotype,Type 1 Diabetes (Age At Diagnosis)
17436,Idp Dmri Probtrackx Icvf Ifo L,Phenotype,Idp Dmri Probtrackx Icvf Ifo L
17438,Atopic Dermatitis,Phenotype,Atopic Dermatitis
17440,Adventurousness,Phenotype,Adventurousness
17442,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease,Phenotype,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease
17444,Idp Dmri Probtrackx Icvf Cgh R,Phenotype,Idp Dmri Probtrackx Icvf Cgh R
17447,Cutaneous Melanoma (Mtag),Phenotype,Cutaneous Melanoma (Mtag)
17454,Ldl Cholesterol X Physical Activity Interaction (2Df Test),Phenotype,Ldl Cholesterol X Physical Activity Interaction (2Df Test)
17455,White Matter Microstructure (Fractional Anisotropy),Phenotype,White Matter Microstructure (Fractional Anisotropy)
17457,Mean Reticulocyte Volume,Phenotype,Mean Reticulocyte Volume
17459,Itch Intensity From Mosquito Bite Adjusted By Bite Size,Phenotype,Itch Intensity From Mosquito Bite Adjusted By Bite Size
17461,Complement Component C8 Levels,Phenotype,Complement Component C8 Levels
17464,Bone Mineral Density (Spine),Phenotype,Bone Mineral Density (Spine)
17467,Concentration Of Chylomicrons And Extremely Large Vldl Particles,Phenotype,Concentration Of Chylomicrons And Extremely Large Vldl Particles
17469,Covid-19 (Hospitalized Covid Vs Population),Phenotype,Covid-19 (Hospitalized Covid Vs Population)
17471,White Coat Effect (Clinic Systolic Blood Pressure Minus Ambulatory Systolic Blood Pressure),Phenotype,White Coat Effect (Clinic Systolic Blood Pressure Minus Ambulatory Systolic Blood Pressure)
17474,Psoriasis,Phenotype,Psoriasis
17476,Inguinal Hernia,Phenotype,Inguinal Hernia
17481,Plasma X-12689 Levels In Chronic Kidney Disease,Phenotype,Plasma X-12689 Levels In Chronic Kidney Disease
17485,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220944),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220944)
17487,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (5992_50),Phenotype,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (5992_50)
17489,Blood Pressure (Pleiotropy Model 1 Dbp Adjusted For Estimated Causal Effects X Sbp),Phenotype,Blood Pressure (Pleiotropy Model 1 Dbp Adjusted For Estimated Causal Effects X Sbp)
17492,Response To Phenytoin In Focal Epilepsy,Phenotype,Response To Phenytoin In Focal Epilepsy
17494,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_235512),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_235512)
17501,Respiratory Disease (Confirmatory Factor Analysis Factor 11),Phenotype,Respiratory Disease (Confirmatory Factor Analysis Factor 11)
17504,Left Ventricle Wall Thickness,Phenotype,Left Ventricle Wall Thickness
17506,Hypothyroidism Or Rheumatoid Arthritis (Pleiotropy),Phenotype,Hypothyroidism Or Rheumatoid Arthritis (Pleiotropy)
17511,Crohn'S Disease X Smoking Status (Never Vs Ever Smoking) Interaction,Phenotype,Crohn'S Disease X Smoking Status (Never Vs Ever Smoking) Interaction
17513,Triglyceride Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Triglyceride Levels In Chylomicrons And Extremely Large Vldl
17517,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze),Phenotype,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze)
17519,Orofacial Clefts,Phenotype,Orofacial Clefts
17522,Rbc Levels Of Pyruvate (Um),Phenotype,Rbc Levels Of Pyruvate (Um)
17524,Neutrophil Percentage Of Granulocytes,Phenotype,Neutrophil Percentage Of Granulocytes
17526,Meat-Related Diet,Phenotype,Meat-Related Diet
17529,Medication Use (Agents Acting On The Renin-Angiotensin System),Phenotype,Medication Use (Agents Acting On The Renin-Angiotensin System)
17531,Pemphigus Vulgaris,Phenotype,Pemphigus Vulgaris
17535,Fev1 Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fev1 Or Irritable Bowel Syndrome (Pleiotropy)
17538,Idp Dmri Tbss L2 Corticospinal Tract R,Phenotype,Idp Dmri Tbss L2 Corticospinal Tract R
17547,Waist-To-Hip Ratio Adjusted For Bmi (Additive Genetic Model),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Additive Genetic Model)
17549,Triglyceride Levels (Mtag),Phenotype,Triglyceride Levels (Mtag)
17551,Total Lipid Levels In Small Hdl,Phenotype,Total Lipid Levels In Small Hdl
17553,Vaginal Microbiome Metacyc Pathway (Centferm-Pwy|Pyruvate Fermentation To Butanoate),Phenotype,Vaginal Microbiome Metacyc Pathway (Centferm-Pwy|Pyruvate Fermentation To Butanoate)
17558,Vaginal Microbiome Metacyc Pathway (Pwy-5862|Superpathway Of Demethylmenaquinol-9 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5862|Superpathway Of Demethylmenaquinol-9 Biosynthesis)
17560,Fasting Insulin (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy),Phenotype,Fasting Insulin (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy)
17563,Colorectal Cancer X Estrogen Hormone Therapy Interaction,Phenotype,Colorectal Cancer X Estrogen Hormone Therapy Interaction
17566,Ldl Cholesterol Levels In Current Drinkers,Phenotype,Ldl Cholesterol Levels In Current Drinkers
17569,Color Vision Defects (Tritan),Phenotype,Color Vision Defects (Tritan)
17573,Covid-19 (Hospitalized Vs Tested-- Not Hospitalized),Phenotype,Covid-19 (Hospitalized Vs Tested-- Not Hospitalized)
17575,Lymphocyte Forward Scatter,Phenotype,Lymphocyte Forward Scatter
17577,Cardiometabolic Multimorbidity,Phenotype,Cardiometabolic Multimorbidity
17579,Systemic Lupus Erythematosus,Phenotype,Systemic Lupus Erythematosus
17583,Lipoprotein (A) Levels,Phenotype,Lipoprotein (A) Levels
17586,Testasv_20 (Phascolarctobacterium) Abundance,Phenotype,Testasv_20 (Phascolarctobacterium) Abundance
17591,Body Fat Distribution (Leg Fat Ratio),Phenotype,Body Fat Distribution (Leg Fat Ratio)
17593,Fvc Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fvc Or Irritable Bowel Syndrome (Pleiotropy)
17596,Cholesterol To Total Lipids Ratio In Very Large Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Very Large Hdl
17598,Cholesteryl Ester (20:3) Levels,Phenotype,Cholesteryl Ester (20:3) Levels
17602,White Matter Microstructure (Mode Of Anisotropy),Phenotype,White Matter Microstructure (Mode Of Anisotropy)
17606,Pierre Robin Sequence Endophenotypic Score,Phenotype,Pierre Robin Sequence Endophenotypic Score
17613,Vaginal Microbiome Metacyc Pathway (Pwy-5182|Toluene Degradation Ii (Aerobic) (Via 4-Methylcatechol)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5182|Toluene Degradation Ii (Aerobic) (Via 4-Methylcatechol))
17615,Bmi (Adjusted For Smoking Behaviour),Phenotype,Bmi (Adjusted For Smoking Behaviour)
17618,High-Density Lipoprotein Levels (Mtag),Phenotype,High-Density Lipoprotein Levels (Mtag)
17622,Nasopharyngeal Carcinoma (Snp X Snp Interaction),Phenotype,Nasopharyngeal Carcinoma (Snp X Snp Interaction)
17624,Depression (Broad),Phenotype,Depression (Broad)
17626,Ischemic Stroke In Diabetes Mellitus,Phenotype,Ischemic Stroke In Diabetes Mellitus
17629,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188119),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188119)
17631,Malignant Lymphoma,Phenotype,Malignant Lymphoma
17635,Red Meat Related Metabolomic Signature,Phenotype,Red Meat Related Metabolomic Signature
17638,Mean Corpuscular Hemoglobin Concentration,Phenotype,Mean Corpuscular Hemoglobin Concentration
17642,Vertex-Wise Cortical Surface Area,Phenotype,Vertex-Wise Cortical Surface Area
17646,Iron Status Biomarkers (Transferrin Levels),Phenotype,Iron Status Biomarkers (Transferrin Levels)
17647,Cd4-Cd8- T Cell Absolute Count,Phenotype,Cd4-Cd8- T Cell Absolute Count
17651,Ovarian Cancer (Mtag),Phenotype,Ovarian Cancer (Mtag)
17653,Refractive Error,Phenotype,Refractive Error
17656,Childhood Wheezing (Late-Onset),Phenotype,Childhood Wheezing (Late-Onset)
17658,Serum Total Protein Levels,Phenotype,Serum Total Protein Levels
17660,F-Small Fish Liking (Derived Food-Liking Factor),Phenotype,F-Small Fish Liking (Derived Food-Liking Factor)
17668,Coronary Artery Disease (Confirmatory Factor Analysis Factor 16),Phenotype,Coronary Artery Disease (Confirmatory Factor Analysis Factor 16)
17670,Alkylphosphatidylethanolamine (O-18:0/22:6) Levels,Phenotype,Alkylphosphatidylethanolamine (O-18:0/22:6) Levels
17673,Pulse Pressure (Bmi Unadjusted),Phenotype,Pulse Pressure (Bmi Unadjusted)
17675,Metabolite Levels (Pyroglutamine),Phenotype,Metabolite Levels (Pyroglutamine)
17680,Mean Spheric Corpuscular Volume,Phenotype,Mean Spheric Corpuscular Volume
17682,Gastroesophageal Reflux Disease,Phenotype,Gastroesophageal Reflux Disease
17686,Total Lipid Levels In Hdl,Phenotype,Total Lipid Levels In Hdl
17691,Medication Use (Calcium Channel Blockers),Phenotype,Medication Use (Calcium Channel Blockers)
17694,Facial Morphology (Profile Nasal Area),Phenotype,Facial Morphology (Profile Nasal Area)
17696,Vaginal Microbiome Metacyc Pathway (Pwy-5863|Superpathway Of Phylloquinol Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5863|Superpathway Of Phylloquinol Biosynthesis)
17699,Gamma Glutamyl Transpeptidase,Phenotype,Gamma Glutamyl Transpeptidase
17701,Free Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Vldl
17704,Schizophrenia Vs Adhd (Ordinary Least Squares (Ols)),Phenotype,Schizophrenia Vs Adhd (Ordinary Least Squares (Ols))
17706,Staphylococcus Aureus Nasal Carriage (Persistent),Phenotype,Staphylococcus Aureus Nasal Carriage (Persistent)
17708,Osteoarthrosis (Time To Event),Phenotype,Osteoarthrosis (Time To Event)
17710,Vaginal Microbiome Relative Abundance (C_Clostridia),Phenotype,Vaginal Microbiome Relative Abundance (C_Clostridia)
17717,Aspartate Aminotransferase-- Cytoplasmic Levels,Phenotype,Aspartate Aminotransferase-- Cytoplasmic Levels
17720,Total Lipid Levels In Idl,Phenotype,Total Lipid Levels In Idl
17721,Alzheimer'S Disease In Apoe E4+ Carriers,Phenotype,Alzheimer'S Disease In Apoe E4+ Carriers
17723,Age-Related Eyesight Deterioration (Confirmatory Factor Analysis Factor 27),Phenotype,Age-Related Eyesight Deterioration (Confirmatory Factor Analysis Factor 27)
17725,Superior Parietal Area (Unadjusted For Global Measures),Phenotype,Superior Parietal Area (Unadjusted For Global Measures)
17727,Education Attainment Or Alcohol Use Disorders,Phenotype,Education Attainment Or Alcohol Use Disorders
17729,Sum Basophil Neutrophil Counts,Phenotype,Sum Basophil Neutrophil Counts
17732,Serum Levels Of Protein Ctnnb1,Phenotype,Serum Levels Of Protein Ctnnb1
17735,Small Nuclear Ribonucleoprotein F Level In Chronic Kidney Disease With Hypertension And No Diabetes (5494_52),Phenotype,Small Nuclear Ribonucleoprotein F Level In Chronic Kidney Disease With Hypertension And No Diabetes (5494_52)
17739,Clopidogrel Active Metabolite Levels,Phenotype,Clopidogrel Active Metabolite Levels
17741,Lat2/Manf Protein Level Ratio,Phenotype,Lat2/Manf Protein Level Ratio
17743,Interferon Gamma Levels,Phenotype,Interferon Gamma Levels
17746,Gallstone Disease,Phenotype,Gallstone Disease
17748,Covid-19 (Severe Respiratory Symptoms Vs Population),Phenotype,Covid-19 (Severe Respiratory Symptoms Vs Population)
17753,Triglycerides In Medium Hdl,Phenotype,Triglycerides In Medium Hdl
17756,Resistant Hypertension,Phenotype,Resistant Hypertension
17759,Bone Mineral Density (Femoral Neck),Phenotype,Bone Mineral Density (Femoral Neck)
17762,Regional Cortical Thickness (Medialorbitofrontal),Phenotype,Regional Cortical Thickness (Medialorbitofrontal)
17765,Glycosyl Ceramide (D18:2/24:1-- D18:1/24:2) Levels In Elite Athletes,Phenotype,Glycosyl Ceramide (D18:2/24:1-- D18:1/24:2) Levels In Elite Athletes
17768,Eudaimonic Well-Being,Phenotype,Eudaimonic Well-Being
17772,Omega-3 Fatty Acid Levels,Phenotype,Omega-3 Fatty Acid Levels
17776,Inferior Parietal Area (Unadjusted For Global Measures),Phenotype,Inferior Parietal Area (Unadjusted For Global Measures)
17780,Phospholipids In Very Small Vldl,Phenotype,Phospholipids In Very Small Vldl
17783,Facial Morphology (Profile Nasal Angle),Phenotype,Facial Morphology (Profile Nasal Angle)
17786,Serum Phosphate Levels,Phenotype,Serum Phosphate Levels
17789,Vertex-Wise Sulcal Depth,Phenotype,Vertex-Wise Sulcal Depth
17792,Periodontitis (Cdc/Aap),Phenotype,Periodontitis (Cdc/Aap)
17796,Total Body Bone Mineral Density,Phenotype,Total Body Bone Mineral Density
17801,Crtam/Gzma Protein Level Ratio,Phenotype,Crtam/Gzma Protein Level Ratio
17804,Asthma And Cardiovascular Disease,Phenotype,Asthma And Cardiovascular Disease
17806,Hemoglobin,Phenotype,Hemoglobin
17814,Bipolar Disorder Or Ulcerative Colitis (Mtag),Phenotype,Bipolar Disorder Or Ulcerative Colitis (Mtag)
17817,Microfibril-Associated Glycoprotein 4 Levels,Phenotype,Microfibril-Associated Glycoprotein 4 Levels
17819,Right-Hemisphere Somatomotor Network To Right-Hemisphere Salience/Ventral Attention Network White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Somatomotor Network To Right-Hemisphere Salience/Ventral Attention Network White-Matter Structural Connectivity
17822,Alanine Aminotransferase Levels,Phenotype,Alanine Aminotransferase Levels
17825,Serum Levels Of Protein Clec4G,Phenotype,Serum Levels Of Protein Clec4G
17829,Cholesteryl Esters In Large Ldl (Ukb Data Field 23534),Phenotype,Cholesteryl Esters In Large Ldl (Ukb Data Field 23534)
17835,Aseg Lh Volume Cerebellum-Cortex,Phenotype,Aseg Lh Volume Cerebellum-Cortex
17838,Waist-To-Hip Ratio Adjusted For Bmi X Sex X Age Interaction (4Df Test),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi X Sex X Age Interaction (4Df Test)
17840,Alcohol Consumption,Phenotype,Alcohol Consumption
17842,Alcoholic Chronic Pancreatitis,Phenotype,Alcoholic Chronic Pancreatitis
17844,Bone Mineral Density (Paediatric-- Total Body Less Head),Phenotype,Bone Mineral Density (Paediatric-- Total Body Less Head)
17846,Tanner 2 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model),Phenotype,Tanner 2 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model)
17849,Major Depressive Episode Treated With Electroconvulsive Therapy,Phenotype,Major Depressive Episode Treated With Electroconvulsive Therapy
17852,Brain Region Volumes,Phenotype,Brain Region Volumes
17857,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis For Main Effect And Physical Activity Interaction),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis For Main Effect And Physical Activity Interaction)
17860,Self-Reported Math Ability (Mtag),Phenotype,Self-Reported Math Ability (Mtag)
17863,Fibrinogen,Phenotype,Fibrinogen
17865,Rbc Levels Of Udp-N-Acetyl-D-Glucosamine,Phenotype,Rbc Levels Of Udp-N-Acetyl-D-Glucosamine
17868,Edge-Level Brain Connectivity (Multivariate Analysis),Phenotype,Edge-Level Brain Connectivity (Multivariate Analysis)
17873,Noncognitive Aspects Of Educational Attainment,Phenotype,Noncognitive Aspects Of Educational Attainment
17875,Age At Menarche,Phenotype,Age At Menarche
17879,Restless Legs Syndrome,Phenotype,Restless Legs Syndrome
17884,Cerebrospinal Fluid Strem-2 Levels,Phenotype,Cerebrospinal Fluid Strem-2 Levels
17887,Coronary Artery Disease In Hypertension,Phenotype,Coronary Artery Disease In Hypertension
17890,Triglycerides To Total Lipids Ratio In Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Large Vldl
17894,Chitinase-3-Like Protein 2 Levels (Chi3L2.9383.24.3),Phenotype,Chitinase-3-Like Protein 2 Levels (Chi3L2.9383.24.3)
17895,Male-Pattern Baldness,Phenotype,Male-Pattern Baldness
17897,Eyebrow Thickness,Phenotype,Eyebrow Thickness
17899,Brevibacillus B Abundance In Stool,Phenotype,Brevibacillus B Abundance In Stool
17904,Monohexosylceramide (D16:1/22:0) Levels,Phenotype,Monohexosylceramide (D16:1/22:0) Levels
17910,Glutamine--Fructose-6-Phosphate Aminotransferase [Isomerizing] 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23669_20),Phenotype,Glutamine--Fructose-6-Phosphate Aminotransferase [Isomerizing] 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23669_20)
17914,Free Cholesterol Levels In Very Large Hdl,Phenotype,Free Cholesterol Levels In Very Large Hdl
17915,Orbital Telorism,Phenotype,Orbital Telorism
17917,Type 2 Diabetes (Adjusted For Bmi),Phenotype,Type 2 Diabetes (Adjusted For Bmi)
17922,Concentration Of Very Large Hdl Particles,Phenotype,Concentration Of Very Large Hdl Particles
17927,Eosinophil Percentage Of White Cells,Phenotype,Eosinophil Percentage Of White Cells
17931,Response To Gabapentin In Female Chronic Pelvic Pain (Side-Effect Burden),Phenotype,Response To Gabapentin In Female Chronic Pelvic Pain (Side-Effect Burden)
17937,Experiencing Mood Swings,Phenotype,Experiencing Mood Swings
17940,Concentration Of Large Hdl Particles,Phenotype,Concentration Of Large Hdl Particles
17942,Endosulfan Levels,Phenotype,Endosulfan Levels
17944,Attention Deficit Hyperactivity Disorder (Combined Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Combined Symptoms)
17946,Biliary Atresia,Phenotype,Biliary Atresia
17950,Primary Open Angle Glaucoma (Multi-Trait Analysis),Phenotype,Primary Open Angle Glaucoma (Multi-Trait Analysis)
17952,Toenail Selenium Levels,Phenotype,Toenail Selenium Levels
17955,Urinary Albumin Excretion Rate In Type 1 Diabetes,Phenotype,Urinary Albumin Excretion Rate In Type 1 Diabetes
17957,Otu97_119 (Desulfovibrio) Prevalence,Phenotype,Otu97_119 (Desulfovibrio) Prevalence
17959,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive),Phenotype,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive)
17964,Ebbinghaus Illusion (Overestimation),Phenotype,Ebbinghaus Illusion (Overestimation)
17967,Phospholipid Levels In Vldl,Phenotype,Phospholipid Levels In Vldl
17970,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (1Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (1Df Test)
17973,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers,Phenotype,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers
17976,Cholesterol Levels In Very Large Vldl,Phenotype,Cholesterol Levels In Very Large Vldl
17977,Triglyceride Levels In Hiv Infection,Phenotype,Triglyceride Levels In Hiv Infection
17979,Ulna And Radius Bone Mineral Density,Phenotype,Ulna And Radius Bone Mineral Density
17981,Serum Albumin Levels,Phenotype,Serum Albumin Levels
17983,Neutrophil Gelatinase-Associated Lipocalin Levels,Phenotype,Neutrophil Gelatinase-Associated Lipocalin Levels
17985,Diacylglycerol(34:2)_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol(34:2)_[M+H-H2O]1+ Levels
17987,Family History Of Alzheimer'S Disease,Phenotype,Family History Of Alzheimer'S Disease
17990,Immature Platelet Count,Phenotype,Immature Platelet Count
17992,Menarche (Age At Onset),Phenotype,Menarche (Age At Onset)
17996,Clostridium Difficile Infection In Multiple Myeloma,Phenotype,Clostridium Difficile Infection In Multiple Myeloma
18001,Major Depressive Disorder Or Stroke (Pleiotropy),Phenotype,Major Depressive Disorder Or Stroke (Pleiotropy)
18004,Common Executive Function,Phenotype,Common Executive Function
18008,Environmental Pollutants Exposure (Rfd High),Phenotype,Environmental Pollutants Exposure (Rfd High)
18012,Sphingomyelin (D18:0/18:0-- D19:0/17:0) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:0/18:0-- D19:0/17:0) Levels In Elite Athletes
18015,Cholesterol Levels In Small Vldl,Phenotype,Cholesterol Levels In Small Vldl
18017,Gastric Atrophy,Phenotype,Gastric Atrophy
18022,Bronchopulmonary Dysplasia,Phenotype,Bronchopulmonary Dysplasia
18026,Granulocyte Percentage Of Myeloid White Cells,Phenotype,Granulocyte Percentage Of Myeloid White Cells
18028,Vaginal Microbiome Relative Abundance (S_Finegoldia Magna),Phenotype,Vaginal Microbiome Relative Abundance (S_Finegoldia Magna)
18030,Birth Weight,Phenotype,Birth Weight
18033,Coronary Artery Disease In Type 1 Diabetes,Phenotype,Coronary Artery Disease In Type 1 Diabetes
18035,General Factor Of Neuroticism,Phenotype,General Factor Of Neuroticism
18037,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test)
18039,Sleep (1-Day Periodicity),Phenotype,Sleep (1-Day Periodicity)
18041,Post-Traumatic Stress Disorder (Asjusted For Relatedness),Phenotype,Post-Traumatic Stress Disorder (Asjusted For Relatedness)
18045,Phosphatidylcholine Acyl-Alkyl C40:5 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C40:5 Levels
18048,Waist-To-Hip Ratio Adjusted For Bmi In Active Individuals,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi In Active Individuals
18053,Ca13/Grap2 Protein Level Ratio,Phenotype,Ca13/Grap2 Protein Level Ratio
18056,Age When Finished Full-Time Education (Weighted Gwa),Phenotype,Age When Finished Full-Time Education (Weighted Gwa)
18058,Gestational Age At Birth In Labor-Initiated Deliveries (Child Effect),Phenotype,Gestational Age At Birth In Labor-Initiated Deliveries (Child Effect)
18060,Albumin Levels,Phenotype,Albumin Levels
18062,High-Sensitivity Cardiac Troponin T Levels,Phenotype,High-Sensitivity Cardiac Troponin T Levels
18065,Postmenopausal Breast Cancer,Phenotype,Postmenopausal Breast Cancer
18067,Coro1A/Tbc1D5 Protein Level Ratio,Phenotype,Coro1A/Tbc1D5 Protein Level Ratio
18072,Vaginal Microbiome Metacyc Pathway (Pwy-6749|Cmp-Legionaminate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6749|Cmp-Legionaminate Biosynthesis I)
18074,Intelligence,Phenotype,Intelligence
18076,Leisure Screen Time,Phenotype,Leisure Screen Time
18080,Left Ventricular Internal Dimension In Systole,Phenotype,Left Ventricular Internal Dimension In Systole
18083,Triacylglycerol(53:3)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(53:3)_[M+Nh4]1+ Levels
18086,Monounsaturated Fatty Acids Levels (Ukb Data Field 23447),Phenotype,Monounsaturated Fatty Acids Levels (Ukb Data Field 23447)
18087,Low-Density Lipoprotein Levels (Mtag),Phenotype,Low-Density Lipoprotein Levels (Mtag)
18089,Coronary Artery Calcification,Phenotype,Coronary Artery Calcification
18091,Concentration Of Medium Vldl Particles (Ukb Data Field 23502),Phenotype,Concentration Of Medium Vldl Particles (Ukb Data Field 23502)
18098,Prostate Cancer (Snp X Snp Interaction),Phenotype,Prostate Cancer (Snp X Snp Interaction)
18101,Total Lipids In Large Hdl (Ukb Data Field 23559),Phenotype,Total Lipids In Large Hdl (Ukb Data Field 23559)
18104,Neutrophil Percentage Of White Cells,Phenotype,Neutrophil Percentage Of White Cells
18106,Valylglycine Levels (Advanced Age),Phenotype,Valylglycine Levels (Advanced Age)
18109,Venous Thromboembolism Or Factor Vii Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Factor Vii Levels (Pleiotropy)
18113,Memory Decline In Normal Cognition,Phenotype,Memory Decline In Normal Cognition
18115,Total Triglycerides Levels (Ukb Data Field 23407),Phenotype,Total Triglycerides Levels (Ukb Data Field 23407)
18117,Cholesterol Levels In Idl,Phenotype,Cholesterol Levels In Idl
18119,Alzheimer’S Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile),Phenotype,Alzheimer’S Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile)
18121,1-Oleoyl-Gpg (18:1) Levels In Elite Athletes,Phenotype,1-Oleoyl-Gpg (18:1) Levels In Elite Athletes
18123,Angiopoietin-1 Levels,Phenotype,Angiopoietin-1 Levels
18125,Serum Creatinine Levels,Phenotype,Serum Creatinine Levels
18130,Blood Pressure Traits (Multi-Trait Analysis),Phenotype,Blood Pressure Traits (Multi-Trait Analysis)
18132,Ability To Confide In Someone,Phenotype,Ability To Confide In Someone
18134,Systemic Lupus Erythematosus (Mtag),Phenotype,Systemic Lupus Erythematosus (Mtag)
18136,Egf/Manf Protein Level Ratio,Phenotype,Egf/Manf Protein Level Ratio
18138,Cholesteryl Ester Levels In Ldl,Phenotype,Cholesteryl Ester Levels In Ldl
18143,Medial Orbital Frontal Cortex Volume,Phenotype,Medial Orbital Frontal Cortex Volume
18145,Ceramide (D40:1) Levels,Phenotype,Ceramide (D40:1) Levels
18149,Body Size (Confirmatory Factor Analysis Factor 21),Phenotype,Body Size (Confirmatory Factor Analysis Factor 21)
18153,Cerebrospinal Fluid Amyloid Beta 42 Levels (12 Month Visit),Phenotype,Cerebrospinal Fluid Amyloid Beta 42 Levels (12 Month Visit)
18155,Lipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Lipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction
18157,Glycoprotein Acetylation,Phenotype,Glycoprotein Acetylation
18159,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose-I),Phenotype,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose-I)
18161,Baseline Memory,Phenotype,Baseline Memory
18164,Cd209 Antigen Levels,Phenotype,Cd209 Antigen Levels
18166,Cardiovascular Disease In Type 2 Diabetes,Phenotype,Cardiovascular Disease In Type 2 Diabetes
18169,Tonsillectomy,Phenotype,Tonsillectomy
18175,Ipcef1/Txlna Protein Level Ratio,Phenotype,Ipcef1/Txlna Protein Level Ratio
18178,Arachidonate 15-Lipoxygenase B Levels (Alox15B.12422.143.3),Phenotype,Arachidonate 15-Lipoxygenase B Levels (Alox15B.12422.143.3)
18184,Concentration Of Idl Particles,Phenotype,Concentration Of Idl Particles
18186,Asthma (Adult Onset),Phenotype,Asthma (Adult Onset)
18188,Phospholipid Levels In Small Ldl,Phenotype,Phospholipid Levels In Small Ldl
18191,Protein Biomarker,Phenotype,Protein Biomarker
18193,Ldl Cholesterol Levels,Phenotype,Ldl Cholesterol Levels
18200,Programmed Cell Death 1 Ligand 2 Levels,Phenotype,Programmed Cell Death 1 Ligand 2 Levels
18202,Vwf And Fviii Levels,Phenotype,Vwf And Fviii Levels
18207,Cholesterol Esters In Medium Vldl,Phenotype,Cholesterol Esters In Medium Vldl
18209,Colorectal Cancer,Phenotype,Colorectal Cancer
18211,Verbal-Numerical Reasoning,Phenotype,Verbal-Numerical Reasoning
18213,Neuronal Pentraxin-2 Levels,Phenotype,Neuronal Pentraxin-2 Levels
18216,Cerebral Aneurysm,Phenotype,Cerebral Aneurysm
18223,Total Cholesterol Levels (Ukb Data Field 23400),Phenotype,Total Cholesterol Levels (Ukb Data Field 23400)
18226,Total Lipids In Small Vldl,Phenotype,Total Lipids In Small Vldl
18229,C3A Anaphylatoxin Levels,Phenotype,C3A Anaphylatoxin Levels
18231,Proteasome Activator Complex Subunit 1 Levels,Phenotype,Proteasome Activator Complex Subunit 1 Levels
18233,Phospholipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23483),Phenotype,Phospholipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23483)
18235,Human Milk Oligosaccharide Concentration (Disialyllacto-N-Hexaose),Phenotype,Human Milk Oligosaccharide Concentration (Disialyllacto-N-Hexaose)
18238,Arthritis (Juvenile Idiopathic),Phenotype,Arthritis (Juvenile Idiopathic)
18240,Glycosphingolipids (D42:2) Levels,Phenotype,Glycosphingolipids (D42:2) Levels
18244,Bipolar I Disorder,Phenotype,Bipolar I Disorder
18246,Life Satisfaction,Phenotype,Life Satisfaction
18248,Relative Protein Intake,Phenotype,Relative Protein Intake
18250,Phospholipids In Idl (Ukb Data Field 23525),Phenotype,Phospholipids In Idl (Ukb Data Field 23525)
18252,Triacylglycerol 56:6 Levels,Phenotype,Triacylglycerol 56:6 Levels
18255,Baseline Memory In Normal Cognition,Phenotype,Baseline Memory In Normal Cognition
18257,Fasting Total Lipids In Large Vldl,Phenotype,Fasting Total Lipids In Large Vldl
18260,Alzheimer'S Disease Or Hdl Levels (Pleiotropy),Phenotype,Alzheimer'S Disease Or Hdl Levels (Pleiotropy)
18262,Crohn'S Disease Or Leprosy (Opposite Effect),Phenotype,Crohn'S Disease Or Leprosy (Opposite Effect)
18266,Serum Levels Of Protein Prss57,Phenotype,Serum Levels Of Protein Prss57
18268,Cervical Cancer (Mtag),Phenotype,Cervical Cancer (Mtag)
18271,Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23615),Phenotype,Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23615)
18273,Monocyte Percentage Of White Cells,Phenotype,Monocyte Percentage Of White Cells
18275,Post-Traumatic Stress Disorder Symptom Severity (Hyperarousal),Phenotype,Post-Traumatic Stress Disorder Symptom Severity (Hyperarousal)
18277,Triglyceride Levels In Idl,Phenotype,Triglyceride Levels In Idl
18281,Baseline Memory In Normal Cognition X Sex Interaction,Phenotype,Baseline Memory In Normal Cognition X Sex Interaction
18283,Triglycerides In Very Small Vldl (Ukb Data Field 23522),Phenotype,Triglycerides In Very Small Vldl (Ukb Data Field 23522)
18285,Mitochondrial Dna Copy Number (Adjusted),Phenotype,Mitochondrial Dna Copy Number (Adjusted)
18289,Memory Decline In Normal Cognition X Sex Interaction,Phenotype,Memory Decline In Normal Cognition X Sex Interaction
18291,Plasma Letrozole Concentrations In Letrozole Treated Hormone-Receptor-Positive Breast Cancer,Phenotype,Plasma Letrozole Concentrations In Letrozole Treated Hormone-Receptor-Positive Breast Cancer
18293,Carotid Intima Media Thickness (Maximum),Phenotype,Carotid Intima Media Thickness (Maximum)
18295,Adenylyltransferase And Sulfurtransferase Mocs3 Levels,Phenotype,Adenylyltransferase And Sulfurtransferase Mocs3 Levels
18297,Medium Chain Acylcarnitines Levels (Dominant Genetic Model),Phenotype,Medium Chain Acylcarnitines Levels (Dominant Genetic Model)
18302,Triglycerides In Large Ldl,Phenotype,Triglycerides In Large Ldl
18304,Serum Galactose-Deficient Iga1 Levels In Iga Nephropathy,Phenotype,Serum Galactose-Deficient Iga1 Levels In Iga Nephropathy
18308,Intake Of Total Sugars,Phenotype,Intake Of Total Sugars
18311,Average Diameter For Vldl Particles (Ukb Data Field 23431),Phenotype,Average Diameter For Vldl Particles (Ukb Data Field 23431)
18315,Myeloid-Derived Growth Factor Levels,Phenotype,Myeloid-Derived Growth Factor Levels
18317,Ldl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (6-Week),Phenotype,Ldl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (6-Week)
18320,1-Stearoyl-2-Arachidonoyl-Gpe (18:0/20:4) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Arachidonoyl-Gpe (18:0/20:4) Levels In Elite Athletes
18325,Daytime Nap,Phenotype,Daytime Nap
18328,S-6-Hydroxywarfarin Levels,Phenotype,S-6-Hydroxywarfarin Levels
18331,Positive Affect,Phenotype,Positive Affect
18333,Docosahexaenoic Acid Levels,Phenotype,Docosahexaenoic Acid Levels
18337,Vldl Cholesterol Levels,Phenotype,Vldl Cholesterol Levels
18338,Chronic Sputum Production,Phenotype,Chronic Sputum Production
18341,Apolipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Apolipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction
18344,Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Large Vldl
18347,Cardiac Mri Latent Space,Phenotype,Cardiac Mri Latent Space
18352,Tyrosine-Protein Kinase Receptor Tie-1-- Soluble Levels (Tie1.2844.53.2),Phenotype,Tyrosine-Protein Kinase Receptor Tie-1-- Soluble Levels (Tie1.2844.53.2)
18358,Migraine - Clinic-Based,Phenotype,Migraine - Clinic-Based
18360,Serum Total Cholesterol Levels,Phenotype,Serum Total Cholesterol Levels
18361,Neurogenic Locus Notch Homolog Protein 1 Levels (Notch1.5107.7.2),Phenotype,Neurogenic Locus Notch Homolog Protein 1 Levels (Notch1.5107.7.2)
18363,Whole Body Fat Mass (Ukb Data Field 23100),Phenotype,Whole Body Fat Mass (Ukb Data Field 23100)
18366,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio,Phenotype,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio
18370,Mesd/Serpinb1 Protein Level Ratio,Phenotype,Mesd/Serpinb1 Protein Level Ratio
18373,Change In Working Memory In Pediatric Cns Tumors Treated With Craniospinal Irradiation,Phenotype,Change In Working Memory In Pediatric Cns Tumors Treated With Craniospinal Irradiation
18379,Cholesterol In Very Large Hdl (Ukb Data Field 23554),Phenotype,Cholesterol In Very Large Hdl (Ukb Data Field 23554)
18382,Soluble Urokinase Plasminogen Activator Receptor Levels,Phenotype,Soluble Urokinase Plasminogen Activator Receptor Levels
18386,Cognitive Performance (Processing Speed),Phenotype,Cognitive Performance (Processing Speed)
18394,Anti-Thyroid Peroxidase (Tpoab) And Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis,Phenotype,Anti-Thyroid Peroxidase (Tpoab) And Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis
18396,Gut Microbiota (Bacterial Taxa-- Hurdle Binary Method),Phenotype,Gut Microbiota (Bacterial Taxa-- Hurdle Binary Method)
18399,Pediatric Autoimmune Diseases,Phenotype,Pediatric Autoimmune Diseases
18401,Glaucoma (Primary Angle Closure),Phenotype,Glaucoma (Primary Angle Closure)
18407,Medication Use (Hmg Coa Reductase Inhibitors),Phenotype,Medication Use (Hmg Coa Reductase Inhibitors)
18412,Cholesterol Esters In Medium Hdl,Phenotype,Cholesterol Esters In Medium Hdl
18414,Total Sitosterol,Phenotype,Total Sitosterol
18417,Total Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Small Vldl
18418,Heart Failure (Multivariate Analysis),Phenotype,Heart Failure (Multivariate Analysis)
18420,Mitochondrial Dna Copy Number (Raw),Phenotype,Mitochondrial Dna Copy Number (Raw)
18423,Periodontal Microbiota,Phenotype,Periodontal Microbiota
18425,Granulocyte Count,Phenotype,Granulocyte Count
18427,Iris Heterochromicity,Phenotype,Iris Heterochromicity
18430,Anxiety X Caesarean-Section Interaction,Phenotype,Anxiety X Caesarean-Section Interaction
18432,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms,Phenotype,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms
18434,Cerebrospinal Fluid (N(1) + N(8))-Acetylspermidine Levels,Phenotype,Cerebrospinal Fluid (N(1) + N(8))-Acetylspermidine Levels
18436,Severe Autoimmune Type 2 Diabetes,Phenotype,Severe Autoimmune Type 2 Diabetes
18439,Fasting Blood Insulin (Bmi Interaction),Phenotype,Fasting Blood Insulin (Bmi Interaction)
18441,Reticulocyte Production Index,Phenotype,Reticulocyte Production Index
18443,Headache,Phenotype,Headache
18445,Delta Of The Red Cell Haemoglobins,Phenotype,Delta Of The Red Cell Haemoglobins
18447,Cognitive Aspects Of Educational Attainment,Phenotype,Cognitive Aspects Of Educational Attainment
18449,Random Glucose Levels,Phenotype,Random Glucose Levels
18450,Polyunsaturated Fatty Acid Levels,Phenotype,Polyunsaturated Fatty Acid Levels
18453,Total Protein Levels X Insomnia Interaction,Phenotype,Total Protein Levels X Insomnia Interaction
18457,Acute Graft-Versus-Host Disease (Stage 3 To 4) (Recipient Effect),Phenotype,Acute Graft-Versus-Host Disease (Stage 3 To 4) (Recipient Effect)
18459,Response To Antipsychotic Treatment,Phenotype,Response To Antipsychotic Treatment
18461,Cholelithiasis,Phenotype,Cholelithiasis
18463,Glucocorticoid-Induced Osteonecrosis,Phenotype,Glucocorticoid-Induced Osteonecrosis
18467,Smoking Initiation (Mtag),Phenotype,Smoking Initiation (Mtag)
18472,Nonsyndromic Cleft Lip With Or Without Cleft Palate,Phenotype,Nonsyndromic Cleft Lip With Or Without Cleft Palate
18474,Acute Lymphoblastic Leukemia (Adolescents And Young Adults),Phenotype,Acute Lymphoblastic Leukemia (Adolescents And Young Adults)
18476,Optic Nerve Measurement (Disc Area),Phenotype,Optic Nerve Measurement (Disc Area)
18478,Glucocorticoid Receptor Gene Expression In B-Cell Precursor Acute Lymphoblastic Leukaemia,Phenotype,Glucocorticoid Receptor Gene Expression In B-Cell Precursor Acute Lymphoblastic Leukaemia
18481,4-Ethylphenylsulfate Levels,Phenotype,4-Ethylphenylsulfate Levels
18483,Weight,Phenotype,Weight
18486,Total Amyloid (Snp X Snp Interaction),Phenotype,Total Amyloid (Snp X Snp Interaction)
18491,Early Cardiac Repolarization,Phenotype,Early Cardiac Repolarization
18493,Blood Pressure,Phenotype,Blood Pressure
18495,Total Fatty Acid Levels,Phenotype,Total Fatty Acid Levels
18497,Serum Levels Of Protein Il15Ra,Phenotype,Serum Levels Of Protein Il15Ra
18499,Non-Lobar Intracerebral Hemorrhage (Mtag),Phenotype,Non-Lobar Intracerebral Hemorrhage (Mtag)
18504,Dkk1/Sdc4 Protein Level Ratio,Phenotype,Dkk1/Sdc4 Protein Level Ratio
18506,Airway Wall Thickness,Phenotype,Airway Wall Thickness
18518,Nonatopic Asthma,Phenotype,Nonatopic Asthma
18522,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (4-Week),Phenotype,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (4-Week)
18526,Environmental Pollutants Exposure (Expo Low),Phenotype,Environmental Pollutants Exposure (Expo Low)
18528,Metabolonic Lactone Sulfate (X-12063) Levels,Phenotype,Metabolonic Lactone Sulfate (X-12063) Levels
18532,Lysophosphatidylcholine (19:0) (A) [Sn1] [104_Sn1] Levels,Phenotype,Lysophosphatidylcholine (19:0) (A) [Sn1] [104_Sn1] Levels
18534,Hepcidin/Ferritin Ratio,Phenotype,Hepcidin/Ferritin Ratio
18536,Pizza Liking,Phenotype,Pizza Liking
18539,Acute Lymphoblastic Leukemia (Childhood),Phenotype,Acute Lymphoblastic Leukemia (Childhood)
18543,Neuritic Plaques (Snp X Snp Interaction),Phenotype,Neuritic Plaques (Snp X Snp Interaction)
18545,Cholesterol Levels In Large Hdl,Phenotype,Cholesterol Levels In Large Hdl
18547,Magnesium Levels,Phenotype,Magnesium Levels
18550,Rest Ukbbica Nodeamps25 0013,Phenotype,Rest Ukbbica Nodeamps25 0013
18552,5-Methylthioadenosine (Mta) Levels In Elite Athletes,Phenotype,5-Methylthioadenosine (Mta) Levels In Elite Athletes
18562,Total Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Total Cholesterol To Total Lipids Ratio In Large Hdl
18571,Never Eat Sugar Vs No Sugar Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Sugar Vs No Sugar Restrictions (Ukb Data Field 6144)
18572,Axin1/Srpk2 Protein Level Ratio,Phenotype,Axin1/Srpk2 Protein Level Ratio
18573,Granulysin Levels,Phenotype,Granulysin Levels
18576,1-Methylhistidine Levels In Elite Athletes,Phenotype,1-Methylhistidine Levels In Elite Athletes
18579,Phosphatidylcholine-O_42:6_[M+Oac]1-/Phosphatidylcholine-P_42:5_[M+Oac]1- Levels,Phenotype,Phosphatidylcholine-O_42:6_[M+Oac]1-/Phosphatidylcholine-P_42:5_[M+Oac]1- Levels
18580,Fatty Acid(20:4)_[M-H]1- Levels,Phenotype,Fatty Acid(20:4)_[M-H]1- Levels
18585,Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- Levels
18590,Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+Nh4]1+ Levels
18592,X-21470 Levels,Phenotype,X-21470 Levels
18595,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels
18597,Diacylglycerol_38:4_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:4_[M+H-H2O]1+ Levels
18599,Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+Nh4]1+ Levels,Phenotype,Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+Nh4]1+ Levels
18601,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score),Phenotype,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score)
18603,Glaucoma (Primary Open-Angle),Phenotype,Glaucoma (Primary Open-Angle)
18605,Colorectal Cancer Or Advanced Adenoma,Phenotype,Colorectal Cancer Or Advanced Adenoma
18608,Major Depressive Disorder And Major Depressive Episode Treated With Electroconvulsive Therapy,Phenotype,Major Depressive Disorder And Major Depressive Episode Treated With Electroconvulsive Therapy
18610,Cholesteryl Esters To Total Lipids In Large Vldl Percentage (Ukb Data Field 23591),Phenotype,Cholesteryl Esters To Total Lipids In Large Vldl Percentage (Ukb Data Field 23591)
18612,Arachidonate (20:4N6) Levels (Elderly Offspring),Phenotype,Arachidonate (20:4N6) Levels (Elderly Offspring)
18615,Sphingomyelin(42:3)_[M+H]1+ Levels,Phenotype,Sphingomyelin(42:3)_[M+H]1+ Levels
18620,Phosphatidylcholine (14:0_20:4) Levels,Phenotype,Phosphatidylcholine (14:0_20:4) Levels
18622,Fatty Acid(22:4)_[M-H]1- Levels,Phenotype,Fatty Acid(22:4)_[M-H]1- Levels
18624,Phosphatidylcholine-2O_32:0_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-2O_32:0_[M+H]1+ Levels
18628,Phosphatidylcholine Diacyl C40:4 Levels,Phenotype,Phosphatidylcholine Diacyl C40:4 Levels
18637,Diacylglycerol (18:1_18:1) Levels,Phenotype,Diacylglycerol (18:1_18:1) Levels
18640,Phosphatidylethanolamine(34:2)_[M+H]1+ Levels,Phenotype,Phosphatidylethanolamine(34:2)_[M+H]1+ Levels
18650,Phospholipid Levels In Large Hdl,Phenotype,Phospholipid Levels In Large Hdl
18652,Response To Tnf Inhibitor In Rheumatoid Arthritis (Change In Tender 28-Joint Count),Phenotype,Response To Tnf Inhibitor In Rheumatoid Arthritis (Change In Tender 28-Joint Count)
18654,Il6 Expression At 6 Weeks In Whole Blood Upon Lps Stimulation In Lyme Borreliosis,Phenotype,Il6 Expression At 6 Weeks In Whole Blood Upon Lps Stimulation In Lyme Borreliosis
18656,Corpus Callosum Mid-Posterior Volume,Phenotype,Corpus Callosum Mid-Posterior Volume
18658,Cholesteryl Ester(20:4)_[M+Nh4]1+ Levels,Phenotype,Cholesteryl Ester(20:4)_[M+Nh4]1+ Levels
18660,Metabolite Peak Levels (Qi7019),Phenotype,Metabolite Peak Levels (Qi7019)
18661,Vaginal Microbiome Metacyc Pathway (Pwy-621|Sucrose Degradation Iii (Sucrose Invertase)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-621|Sucrose Degradation Iii (Sucrose Invertase))
18664,Protein Fam134B Levels,Phenotype,Protein Fam134B Levels
18666,Eosinophil Percentage Of Granulocytes,Phenotype,Eosinophil Percentage Of Granulocytes
18669,Triglycerides To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23588),Phenotype,Triglycerides To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23588)
18673,Qrs Duration In Tripanosoma Cruzi Seropositivity,Phenotype,Qrs Duration In Tripanosoma Cruzi Seropositivity
18675,1-(1-Enyl-Stearoyl)-2-Linoleoyl-Gpe (P-18:0/18:2) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Linoleoyl-Gpe (P-18:0/18:2) Levels
18678,Icd10 J30: Vasomotor And Allergic Rhinitis,Phenotype,Icd10 J30: Vasomotor And Allergic Rhinitis
18683,Allergic Disease (Asthma-- Hay Fever Or Eczema),Phenotype,Allergic Disease (Asthma-- Hay Fever Or Eczema)
18686,Phospholipids In Large Hdl (Ukb Data Field 23560),Phenotype,Phospholipids In Large Hdl (Ukb Data Field 23560)
18687,Erythrocyte Cadmium Concentration,Phenotype,Erythrocyte Cadmium Concentration
18689,Total Cholesterol To Total Lipids Ratio In Idl,Phenotype,Total Cholesterol To Total Lipids Ratio In Idl
18695,Hdl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Hdl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
18697,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+Nh4]1+ Levels
18700,Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- Levels
18702,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ Levels
18704,Glutaminyl-Peptide Cyclotransferase Levels,Phenotype,Glutaminyl-Peptide Cyclotransferase Levels
18706,1-Meadoyl-Gpc (20:3N9) Levels,Phenotype,1-Meadoyl-Gpc (20:3N9) Levels
18712,Blood Glucose Levels,Phenotype,Blood Glucose Levels
18715,Serum Metabolite Levels (Cms),Phenotype,Serum Metabolite Levels (Cms)
18717,Cd3 On Naive Cd8+ T Cell,Phenotype,Cd3 On Naive Cd8+ T Cell
18720,Dyslexia,Phenotype,Dyslexia
18723,Lysophosphatidylcholine (20:2) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (20:2) [Sn2] Levels
18725,Hearing Problems,Phenotype,Hearing Problems
18727,Parental Extreme Longevity (95 Years And Older),Phenotype,Parental Extreme Longevity (95 Years And Older)
18729,Triglycerides To Total Lipids Ratio In Small Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Small Vldl
18732,Phosphatidylglycerol(36:0)_[M-H]1- Levels,Phenotype,Phosphatidylglycerol(36:0)_[M-H]1- Levels
18735,Itgb1Bp2/Mitd1 Protein Level Ratio,Phenotype,Itgb1Bp2/Mitd1 Protein Level Ratio
18737,Sterol Ester (27:1/17:1) Levels,Phenotype,Sterol Ester (27:1/17:1) Levels
18739,Cognitive Performance,Phenotype,Cognitive Performance
18744,1-Arachidonoyl-Gpa (20:4) Levels,Phenotype,1-Arachidonoyl-Gpa (20:4) Levels
18747,Fusiform Gyrus Volume,Phenotype,Fusiform Gyrus Volume
18756,Brugada Syndrome,Phenotype,Brugada Syndrome
18758,Uterine Fibroids,Phenotype,Uterine Fibroids
18760,Vitamin E Levels,Phenotype,Vitamin E Levels
18764,Phosphatidylcholine (18:0_22:5) (N6) Levels,Phenotype,Phosphatidylcholine (18:0_22:5) (N6) Levels
18766,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ Levels
18767,Phosphatidylcholine_44:5_[M+Oac]1- Levels,Phenotype,Phosphatidylcholine_44:5_[M+Oac]1- Levels
18769,Phosphatidylinositol (18:0_18:1) Levels,Phenotype,Phosphatidylinositol (18:0_18:1) Levels
18770,Switch-Associated Protein 70 Levels,Phenotype,Switch-Associated Protein 70 Levels
18773,Skin Phototype Score,Phenotype,Skin Phototype Score
18775,Response To Efavirenz-Containing Treatment In Hiv 1 Infection (Virologic Failure),Phenotype,Response To Efavirenz-Containing Treatment In Hiv 1 Infection (Virologic Failure)
18788,Progressive Supranuclear Palsy,Phenotype,Progressive Supranuclear Palsy
18790,Ccn2/Eno2 Protein Level Ratio,Phenotype,Ccn2/Eno2 Protein Level Ratio
18792,Metabolite Levels (Betaine),Phenotype,Metabolite Levels (Betaine)
18798,Omega-3 Fatty Acids Levels,Phenotype,Omega-3 Fatty Acids Levels
18801,Hbegf/Pdgfa Protein Level Ratio,Phenotype,Hbegf/Pdgfa Protein Level Ratio
18803,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy)
18805,Urine Methylsuccinoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Urine Methylsuccinoylcarnitine Levels In Chronic Kidney Disease
18809,Cd27 On Memory B Cell,Phenotype,Cd27 On Memory B Cell
18821,Vaginal Microbiome Metacyc Pathway (Pyridnucsyn-Pwy|Nad Biosynthesis I (From Aspartate)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pyridnucsyn-Pwy|Nad Biosynthesis I (From Aspartate))
18824,Resting-State Electroencephalogram Vigilance,Phenotype,Resting-State Electroencephalogram Vigilance
18827,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio,Phenotype,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio
18830,Ratio Of Triglycerides To Phosphoglycerides,Phenotype,Ratio Of Triglycerides To Phosphoglycerides
18837,Ascending Thoracic Aortic Diameter,Phenotype,Ascending Thoracic Aortic Diameter
18839,Free Cholesterol In Large Hdl (Ukb Data Field 23563),Phenotype,Free Cholesterol In Large Hdl (Ukb Data Field 23563)
18841,Leukocyte Telomere Length,Phenotype,Leukocyte Telomere Length
18843,Deoxycarnitine Levels,Phenotype,Deoxycarnitine Levels
18846,Glioma Pathogenesis-Related Protein 1 Levels,Phenotype,Glioma Pathogenesis-Related Protein 1 Levels
18848,Cholesterol Esters In Large Hdl,Phenotype,Cholesterol Esters In Large Hdl
18850,Hip Circumference,Phenotype,Hip Circumference
18853,Low-Carbohydrate Diet (Lcd) Score,Phenotype,Low-Carbohydrate Diet (Lcd) Score
18865,Glomerular Filtration Rate,Phenotype,Glomerular Filtration Rate
18869,Cardiovascular Disease,Phenotype,Cardiovascular Disease
18875,Breast Cancer In Brca1 Mutation Carriers,Phenotype,Breast Cancer In Brca1 Mutation Carriers
18881,Cd300C/Clec14A Protein Level Ratio,Phenotype,Cd300C/Clec14A Protein Level Ratio
18888,Lysophosphatidylinositol (20:4) [Sn2] Levels,Phenotype,Lysophosphatidylinositol (20:4) [Sn2] Levels
18890,Glycerophosphoethanolamine Levels In Elite Athletes,Phenotype,Glycerophosphoethanolamine Levels In Elite Athletes
18893,Non-Albumin Protein Levels,Phenotype,Non-Albumin Protein Levels
18895,Type 2 Diabetes Mellitus Adjusted For Bmi Or Coronary Artery Disease (Pleiotropy),Phenotype,Type 2 Diabetes Mellitus Adjusted For Bmi Or Coronary Artery Disease (Pleiotropy)
18897,Alzheimer'S Disease,Phenotype,Alzheimer'S Disease
18900,Gamma-Glutamylphenylalanine Levels,Phenotype,Gamma-Glutamylphenylalanine Levels
18903,Aspartate Levels,Phenotype,Aspartate Levels
18905,Skull Bone Mineral Density,Phenotype,Skull Bone Mineral Density
18910,Celiac Disease,Phenotype,Celiac Disease
18913,Phenylalanine Levels (Ukb Data Field 23468),Phenotype,Phenylalanine Levels (Ukb Data Field 23468)
18915,Vaginal Microbiome Metacyc Pathway (Pwy-5415|Catechol Degradation I (Meta-Cleavage Pathway)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5415|Catechol Degradation I (Meta-Cleavage Pathway))
18919,Free Cholesterol Levels,Phenotype,Free Cholesterol Levels
18922,Serum Levels Of Protein Scin,Phenotype,Serum Levels Of Protein Scin
18925,Headache Or Migraine,Phenotype,Headache Or Migraine
18928,Alzheimer'S Disease In Non-Apoe E4 Carriers,Phenotype,Alzheimer'S Disease In Non-Apoe E4 Carriers
18931,Adiponectin Levels,Phenotype,Adiponectin Levels
18933,Hippocampal Subfield Left Ca4 Volume (Body),Phenotype,Hippocampal Subfield Left Ca4 Volume (Body)
18945,Waist Circumference Adjusted For Bmi (Adjusted For Smoking Behaviour),Phenotype,Waist Circumference Adjusted For Bmi (Adjusted For Smoking Behaviour)
18949,Icd10 J36: Peritonsillar Abscess,Phenotype,Icd10 J36: Peritonsillar Abscess
18953,Metabolite Levels (Taurocholenate Sulfate),Phenotype,Metabolite Levels (Taurocholenate Sulfate)
18955,Clec1B/Nsfl1C Protein Level Ratio,Phenotype,Clec1B/Nsfl1C Protein Level Ratio
18962,Glutamate Levels,Phenotype,Glutamate Levels
18967,Body Mass Index Or Osteoarthritis (Pleiotropy),Phenotype,Body Mass Index Or Osteoarthritis (Pleiotropy)
18970,Parkinson'S Disease (Age Of Onset),Phenotype,Parkinson'S Disease (Age Of Onset)
18976,Serum Uric Acid Levels,Phenotype,Serum Uric Acid Levels
18980,Verbal Learning (Visual Presentation),Phenotype,Verbal Learning (Visual Presentation)
18982,Ccr2 On Cd14- Cd16-,Phenotype,Ccr2 On Cd14- Cd16-
18984,Major Depressive Disorder (Broad),Phenotype,Major Depressive Disorder (Broad)
18986,Cd69/F11R Protein Level Ratio,Phenotype,Cd69/F11R Protein Level Ratio
18988,Glutamine Levels,Phenotype,Glutamine Levels
18993,Fibroblast Growth Factor 23 Levels,Phenotype,Fibroblast Growth Factor 23 Levels
18995,White Blood Cell Count (Monocyte),Phenotype,White Blood Cell Count (Monocyte)
18999,Plasma Amyloid Beta Peptide Concentrations (Abx-40),Phenotype,Plasma Amyloid Beta Peptide Concentrations (Abx-40)
19002,Switched Memory B Cell Absolute Count,Phenotype,Switched Memory B Cell Absolute Count
19009,Cognitive Function (Generalized Correlation Coefficient),Phenotype,Cognitive Function (Generalized Correlation Coefficient)
19014,Age-Related Macular Degeneration,Phenotype,Age-Related Macular Degeneration
19017,Vaginal Microbiome Metacyc Pathway (Pwy-5705|Allantoin Degradation To Glyoxylate Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5705|Allantoin Degradation To Glyoxylate Iii)
19019,Collagen Type Ii Levels,Phenotype,Collagen Type Ii Levels
19027,Visceral Adipose Tissue Adjusted For Bmi,Phenotype,Visceral Adipose Tissue Adjusted For Bmi
19030,Telomere Length (Principal Component 1),Phenotype,Telomere Length (Principal Component 1)
19032,Glomerular Load Of Uric Acid,Phenotype,Glomerular Load Of Uric Acid
19036,Low Hand Grip Strength (60 Years And Older) (Ewgsop),Phenotype,Low Hand Grip Strength (60 Years And Older) (Ewgsop)
19046,Craniofacial Microsomia,Phenotype,Craniofacial Microsomia
19048,Cognitive Function (Kinship Model),Phenotype,Cognitive Function (Kinship Model)
19050,Gamma-Cehc Levels In Elite Athletes,Phenotype,Gamma-Cehc Levels In Elite Athletes
19057,Hepatitis,Phenotype,Hepatitis
19059,Uterine Fibroids (Mtag),Phenotype,Uterine Fibroids (Mtag)
19061,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [1] Levels In Elite Athletes,Phenotype,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [1] Levels In Elite Athletes
19064,Guanine Nucleotide Exchange Factor Dbs Levels,Phenotype,Guanine Nucleotide Exchange Factor Dbs Levels
19067,Hypothyroidism,Phenotype,Hypothyroidism
19073,Covid-19 (Severe Vs Population) X Multiple Deprivation Index Interaction,Phenotype,Covid-19 (Severe Vs Population) X Multiple Deprivation Index Interaction
19076,Coagulation Factor Xa Levels,Phenotype,Coagulation Factor Xa Levels
19079,Ischemic Stroke (Large Artery Atherosclerosis),Phenotype,Ischemic Stroke (Large Artery Atherosclerosis)
19081,Preeclampsia Or Eclampsia,Phenotype,Preeclampsia Or Eclampsia
19084,Lung Function (Fev1/Fvc),Phenotype,Lung Function (Fev1/Fvc)
19088,Leucine Levels In Elite Athletes,Phenotype,Leucine Levels In Elite Athletes
19091,Vaginal Microbiome Relative Abundance (F_Lachnospiraceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Lachnospiraceae)
19096,Propionylcarnitine (C3) Levels,Phenotype,Propionylcarnitine (C3) Levels
19098,Triglyceride Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Triglyceride Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder
19102,Vaginal Microbiome Metacyc Pathway (Pwy-7431|Aromatic Biogenic Amine Degradation (Bacteria)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7431|Aromatic Biogenic Amine Degradation (Bacteria))
19104,Intelligence (Mtag),Phenotype,Intelligence (Mtag)
19107,Dental Development,Phenotype,Dental Development
19110,Irritable Temperament,Phenotype,Irritable Temperament
19115,Verbal Short Term Memory (Paragraph Recall Test),Phenotype,Verbal Short Term Memory (Paragraph Recall Test)
19118,Phospholipids To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23639),Phenotype,Phospholipids To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23639)
19120,Hippocampal Volume In Mild Cognitive Impairment,Phenotype,Hippocampal Volume In Mild Cognitive Impairment
19122,Tuberculosis,Phenotype,Tuberculosis
19124,Protocadherin-9 Levels,Phenotype,Protocadherin-9 Levels
19131,Nrcam/Pcdh17 Protein Level Ratio,Phenotype,Nrcam/Pcdh17 Protein Level Ratio
19133,Platelet Count During  Second Trimester Of Pregnancy,Phenotype,Platelet Count During  Second Trimester Of Pregnancy
19135,Middle Temporal Gyrus Volume,Phenotype,Middle Temporal Gyrus Volume
19137,Suicide,Phenotype,Suicide
19140,Serum Nickel Levels,Phenotype,Serum Nickel Levels
19143,Placental Abruption,Phenotype,Placental Abruption
19146,Reaction Time (Standard Gwa),Phenotype,Reaction Time (Standard Gwa)
19150,Concentration Of Very Large Vldl Particles,Phenotype,Concentration Of Very Large Vldl Particles
19152,Systolic Blood Pressure (Mtag),Phenotype,Systolic Blood Pressure (Mtag)
19154,Tauroursodeoxycholate Levels In Elite Athletes,Phenotype,Tauroursodeoxycholate Levels In Elite Athletes
19161,Diabetes (Standard Gwa),Phenotype,Diabetes (Standard Gwa)
19163,Smoking Status (Ever Vs Never Smokers),Phenotype,Smoking Status (Ever Vs Never Smokers)
19165,B Cell Lymphocyte Profile Difference,Phenotype,B Cell Lymphocyte Profile Difference
19169,Platelet Reactivity In Response To Clopidogrel Treatment,Phenotype,Platelet Reactivity In Response To Clopidogrel Treatment
19172,Acute Post-Radiotherapy Pain In Breast Cancer,Phenotype,Acute Post-Radiotherapy Pain In Breast Cancer
19174,Serum Levels Of Protein Apln,Phenotype,Serum Levels Of Protein Apln
19176,Multisite Chronic Pain,Phenotype,Multisite Chronic Pain
19180,Thrombocytopenia In Coronary Artery Bypass Surgery,Phenotype,Thrombocytopenia In Coronary Artery Bypass Surgery
19182,Inflammatory Or Infectious Upper Respiratory Disease,Phenotype,Inflammatory Or Infectious Upper Respiratory Disease
19188,Caudate Activity During Reward,Phenotype,Caudate Activity During Reward
19192,Schizophrenia-- Bipolar Disorder Or Recurrent Major Depressive Disorder X Sex Interaction (3Df),Phenotype,Schizophrenia-- Bipolar Disorder Or Recurrent Major Depressive Disorder X Sex Interaction (3Df)
19200,Autism Spectrum Disorder,Phenotype,Autism Spectrum Disorder
19203,Hemoglobin A1C Levels,Phenotype,Hemoglobin A1C Levels
19207,Rate Of Ventricular Enlargement,Phenotype,Rate Of Ventricular Enlargement
19209,Chronic Obstructive Pulmonary Disease (Severe),Phenotype,Chronic Obstructive Pulmonary Disease (Severe)
19222,Posterior Thalamic Nuclei Volume,Phenotype,Posterior Thalamic Nuclei Volume
19226,Serum Levels Of Protein Ambn,Phenotype,Serum Levels Of Protein Ambn
19230,Overall Survival In Serous Epithelial Ovarian Cancer Treated With Paclitaxel And Cisplatin,Phenotype,Overall Survival In Serous Epithelial Ovarian Cancer Treated With Paclitaxel And Cisplatin
19234,Concentration Of Medium Ldl Particles,Phenotype,Concentration Of Medium Ldl Particles
19236,Sphingomyelin_39:1_[M+H]1+ Levels,Phenotype,Sphingomyelin_39:1_[M+H]1+ Levels
19238,Cancer,Phenotype,Cancer
19241,Morning Person,Phenotype,Morning Person
19245,Multiple Myeloma (Hyperdiploidy),Phenotype,Multiple Myeloma (Hyperdiploidy)
19247,Severe Influenza A (H1N1) Infection,Phenotype,Severe Influenza A (H1N1) Infection
19249,Liver Fibrosis And Steatohepatitis Severity (Mri Ct1 Measure),Phenotype,Liver Fibrosis And Steatohepatitis Severity (Mri Ct1 Measure)
19251,Plasma Tetradecadienedioate (C14:2-Dc)* Levels In Chronic Kidney Disease,Phenotype,Plasma Tetradecadienedioate (C14:2-Dc)* Levels In Chronic Kidney Disease
19257,Complement C1Q Tumor Necrosis Factor-Related Protein 1 Levels,Phenotype,Complement C1Q Tumor Necrosis Factor-Related Protein 1 Levels
19259,Hepatitis B,Phenotype,Hepatitis B
19261,Basophil Percentage Of White Cells,Phenotype,Basophil Percentage Of White Cells
19264,Visfatin Levels,Phenotype,Visfatin Levels
19267,Sphingomyelin_33:1_[M+H]1+ Levels,Phenotype,Sphingomyelin_33:1_[M+H]1+ Levels
19273,Cathepsin L1 Levels,Phenotype,Cathepsin L1 Levels
19275,Maleylacetoacetate Isomerase Levels,Phenotype,Maleylacetoacetate Isomerase Levels
19277,1-Stearoyl-2-Oleoyl-Gpi (18:0/18:1) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Oleoyl-Gpi (18:0/18:1) Levels In Elite Athletes
19279,Alzheimer'S Disease Or Gastroesophageal Reflux Disease,Phenotype,Alzheimer'S Disease Or Gastroesophageal Reflux Disease
19282,Igg Glycosylation Patterns,Phenotype,Igg Glycosylation Patterns
19284,Diacylglycerol_42:7_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_42:7_[M+H-H2O]1+ Levels
19288,Vaginal Microbiome Metacyc Pathway (Rump-Pwy|Formaldehyde Oxidation I),Phenotype,Vaginal Microbiome Metacyc Pathway (Rump-Pwy|Formaldehyde Oxidation I)
19291,Thioredoxin Domain-Containing Protein 5 Levels (Txndc5.11212.7.3),Phenotype,Thioredoxin Domain-Containing Protein 5 Levels (Txndc5.11212.7.3)
19292,Testasv_28 (Holdemanella) Prevalence,Phenotype,Testasv_28 (Holdemanella) Prevalence
19296,Major Coronary Event In Cardiovascular Disease (Time To Event) (Darapladib Treatment Interaction),Phenotype,Major Coronary Event In Cardiovascular Disease (Time To Event) (Darapladib Treatment Interaction)
19298,Familial Squamous Cell Lung Carcinoma,Phenotype,Familial Squamous Cell Lung Carcinoma
19301,Triglycerides In Small Ldl,Phenotype,Triglycerides In Small Ldl
19304,Bitter Alcoholic Beverage Consumption,Phenotype,Bitter Alcoholic Beverage Consumption
19310,X-21411 Levels,Phenotype,X-21411 Levels
19313,Iris Color (B* Coordinate),Phenotype,Iris Color (B* Coordinate)
19315,Serum Levels Of Protein Ptprn2,Phenotype,Serum Levels Of Protein Ptprn2
19317,Testasv_48 (Sutterella) Abundance,Phenotype,Testasv_48 (Sutterella) Abundance
19320,Seropositivity For Bacteroides Uniformis (Agilent_127067),Phenotype,Seropositivity For Bacteroides Uniformis (Agilent_127067)
19324,Tenofovir Clearance In Hiv Infection,Phenotype,Tenofovir Clearance In Hiv Infection
19329,N-Palmitoyl-Heptadecasphingosine (D17:1/16:0) Levels,Phenotype,N-Palmitoyl-Heptadecasphingosine (D17:1/16:0) Levels
19331,Sphingomyelin 24:0 Levels,Phenotype,Sphingomyelin 24:0 Levels
19333,Abdominal Fat Cell Number,Phenotype,Abdominal Fat Cell Number
19336,Clinical Ldl Cholesterol Levels,Phenotype,Clinical Ldl Cholesterol Levels
19342,Ectonucleoside Triphosphate Diphosphohydrolase 5 Levels,Phenotype,Ectonucleoside Triphosphate Diphosphohydrolase 5 Levels
19345,Triglyceride Levels X Loop Diuretics Use Interaction,Phenotype,Triglyceride Levels X Loop Diuretics Use Interaction
19350,Paired Immunoglobulin-Like Type 2 Receptor Alpha Levels (Pilra.8683.119.3),Phenotype,Paired Immunoglobulin-Like Type 2 Receptor Alpha Levels (Pilra.8683.119.3)
19355,Environmental Pollutants Exposure (Ac50 Low),Phenotype,Environmental Pollutants Exposure (Ac50 Low)
19359,Pallidum Volume,Phenotype,Pallidum Volume
19361,Problematic Alcohol Use,Phenotype,Problematic Alcohol Use
19367,Peanut Allergy,Phenotype,Peanut Allergy
19369,G_Parasutterella Prevalence,Phenotype,G_Parasutterella Prevalence
19373,Osm/Tgfa Protein Level Ratio,Phenotype,Osm/Tgfa Protein Level Ratio
19375,Vaginal Microbiome Relative Abundance (S_Lactobacillus Iners),Phenotype,Vaginal Microbiome Relative Abundance (S_Lactobacillus Iners)
19378,Aparc-Desikan Rh Area Cuneus,Phenotype,Aparc-Desikan Rh Area Cuneus
19379,Metabolite Peak Levels (Qi9774),Phenotype,Metabolite Peak Levels (Qi9774)
19386,Alpha-1-Antitrypsin Level In Chronic Kidney Disease With Hypertension And No Diabetes (3580_25),Phenotype,Alpha-1-Antitrypsin Level In Chronic Kidney Disease With Hypertension And No Diabetes (3580_25)
19390,Chronic Sinusitis,Phenotype,Chronic Sinusitis
19392,Cortical Surface Area (Visual Pc2),Phenotype,Cortical Surface Area (Visual Pc2)
19395,Plasma Free Amino Acid Levels (Adjusted For One Other Pfaa),Phenotype,Plasma Free Amino Acid Levels (Adjusted For One Other Pfaa)
19397,Systolic Blood Pressure (Standard Gwa),Phenotype,Systolic Blood Pressure (Standard Gwa)
19402,Diacylglycerol_38:6_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:6_[M+H-H2O]1+ Levels
19405,Antipsychotic Drug Dosage In Schizophrenia Or Schizoaffective Disorder,Phenotype,Antipsychotic Drug Dosage In Schizophrenia Or Schizoaffective Disorder
19413,2-Stearoyl-Gpe (18:0) Levels,Phenotype,2-Stearoyl-Gpe (18:0) Levels
19417,Dapp1/Manf Protein Level Ratio,Phenotype,Dapp1/Manf Protein Level Ratio
19421,Aging (Eyeageacceleration),Phenotype,Aging (Eyeageacceleration)
19423,Cannabis Smoking Or Cigarette Smoking Or Schizophrenia,Phenotype,Cannabis Smoking Or Cigarette Smoking Or Schizophrenia
19428,Chronic Obstructive Pulmonary Disease In Ever Smokers,Phenotype,Chronic Obstructive Pulmonary Disease In Ever Smokers
19432,Eye Color,Phenotype,Eye Color
19434,Regional Cortical Thickness (Insula),Phenotype,Regional Cortical Thickness (Insula)
19436,Brown Vs. Black Hair Color,Phenotype,Brown Vs. Black Hair Color
19441,Cholesterol To Total Lipids Ratio In Very Small Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Very Small Vldl
19446,Albumin Levels (Ukb Data Field 23479),Phenotype,Albumin Levels (Ukb Data Field 23479)
19449,Omega-6 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23452),Phenotype,Omega-6 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23452)
19452,Childhood Maltreatment,Phenotype,Childhood Maltreatment
19456,Dab2/Erbin Protein Level Ratio,Phenotype,Dab2/Erbin Protein Level Ratio
19462,Basophil Forward Scatter Distribution Width,Phenotype,Basophil Forward Scatter Distribution Width
19465,Receptor Tyrosine-Protein Kinase Erbb-3 Levels,Phenotype,Receptor Tyrosine-Protein Kinase Erbb-3 Levels
19472,Risk-Taking Behavior (Multivariate Analysis),Phenotype,Risk-Taking Behavior (Multivariate Analysis)
19474,Free Cholesterol In Large Vldl (Ukb Data Field 23500),Phenotype,Free Cholesterol In Large Vldl (Ukb Data Field 23500)
19477,Lung Cancer In Ever Smokers,Phenotype,Lung Cancer In Ever Smokers
19480,Lysophosphatidylethanolamine (17:0) [Sn2] Levels,Phenotype,Lysophosphatidylethanolamine (17:0) [Sn2] Levels
19484,Glomerular Filtration Rate (Creatinine),Phenotype,Glomerular Filtration Rate (Creatinine)
19488,Total Cholesterol In Hdl2,Phenotype,Total Cholesterol In Hdl2
19489,Thyroid Hormone Levels,Phenotype,Thyroid Hormone Levels
19492,Preeclampsia Or Other Maternal Hypertension (Maternal Genotype Effect),Phenotype,Preeclampsia Or Other Maternal Hypertension (Maternal Genotype Effect)
19497,Skin Color (Fitzpatrick Scale),Phenotype,Skin Color (Fitzpatrick Scale)
19499,Phosphatidylcholines Levels (Ukb Data Field 23437),Phenotype,Phosphatidylcholines Levels (Ukb Data Field 23437)
19501,Diffusing Capacity Of Carbon Monoxide,Phenotype,Diffusing Capacity Of Carbon Monoxide
19505,Total Cholesterol Levels In Very Large Hdl,Phenotype,Total Cholesterol Levels In Very Large Hdl
19508,Hdl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Hdl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
19512,Matrix-Remodeling-Associated Protein 8 Levels,Phenotype,Matrix-Remodeling-Associated Protein 8 Levels
19515,Phosphatidylethanolamine(36:4)_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine(36:4)_[M-H]1- Levels
19517,Insulin-Like Growth Factor 1 Levels,Phenotype,Insulin-Like Growth Factor 1 Levels
19519,Monoclonal Gammopathy Of Undetermined Significance,Phenotype,Monoclonal Gammopathy Of Undetermined Significance
19521,Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+Nh4]1+ Levels
19525,Triglycerides To Total Lipids In Small Hdl Percentage (Ukb Data Field 23648),Phenotype,Triglycerides To Total Lipids In Small Hdl Percentage (Ukb Data Field 23648)
19527,Hip Minimal Joint Space Width,Phenotype,Hip Minimal Joint Space Width
19531,1-Palmitoyl-Gpe (16:0) Levels,Phenotype,1-Palmitoyl-Gpe (16:0) Levels
19535,Sphingomyelins Levels (Ukb Data Field 23438),Phenotype,Sphingomyelins Levels (Ukb Data Field 23438)
19537,Tourette Syndrome,Phenotype,Tourette Syndrome
19546,Aspartate Aminotransferase To Alanine Aminotransferase Ratio,Phenotype,Aspartate Aminotransferase To Alanine Aminotransferase Ratio
19548,Febrile Seizures (Mmr Vaccine-Related),Phenotype,Febrile Seizures (Mmr Vaccine-Related)
19550,Triglycerides To Total Lipids In Large Vldl Percentage (Ukb Data Field 23593),Phenotype,Triglycerides To Total Lipids In Large Vldl Percentage (Ukb Data Field 23593)
19552,High-Sensitivity Cardiac Troponin I Concentration,Phenotype,High-Sensitivity Cardiac Troponin I Concentration
19554,Ppp1R12A/Txndc5 Protein Level Ratio,Phenotype,Ppp1R12A/Txndc5 Protein Level Ratio
19556,Triglycerides To Total Lipids Ratio In Very Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Very Large Vldl
19558,Phosphatidylethanolamine(36:4)_[M+H]1+ Levels,Phenotype,Phosphatidylethanolamine(36:4)_[M+H]1+ Levels
19562,Urinary Albumin-To-Creatinine Ratio,Phenotype,Urinary Albumin-To-Creatinine Ratio
19564,Predicted Developmental Stuttering,Phenotype,Predicted Developmental Stuttering
19566,Free Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Vldl
19568,Age-Related Macular Degeneration (Snp X Mitochondrial A4917G Interaction),Phenotype,Age-Related Macular Degeneration (Snp X Mitochondrial A4917G Interaction)
19571,Fasting Total Cholesterol In Idl,Phenotype,Fasting Total Cholesterol In Idl
19572,Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+Nh4]1+ Levels
19574,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test)
19576,Free Cholesterol Levels In Large Hdl,Phenotype,Free Cholesterol Levels In Large Hdl
19578,Dual Specificity Mitogen-Activated Protein Kinase Kinase 1 Levels,Phenotype,Dual Specificity Mitogen-Activated Protein Kinase Kinase 1 Levels
19580,Phosphatidylcholine Acyl-Alkyl C36:3 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C36:3 Levels
19583,Periventricular White Matter Hyperintensities,Phenotype,Periventricular White Matter Hyperintensities
19587,Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Large Hdl
19588,General Risk Tolerance (Mtag),Phenotype,General Risk Tolerance (Mtag)
19591,Phosphatidylethanolamine (18:0_20:4) Levels,Phenotype,Phosphatidylethanolamine (18:0_20:4) Levels
19593,Global Cognition (Mini Mental State Examination),Phenotype,Global Cognition (Mini Mental State Examination)
19595,Emphysema Distribution In Smoking,Phenotype,Emphysema Distribution In Smoking
19599,Urea Levels,Phenotype,Urea Levels
19602,Myeloid White Cell Count,Phenotype,Myeloid White Cell Count
19604,Glomerular Filtration Rate In Non Diabetics (Creatinine),Phenotype,Glomerular Filtration Rate In Non Diabetics (Creatinine)
19608,Liver Enzyme Levels (Gamma-Glutamyl Transferase),Phenotype,Liver Enzyme Levels (Gamma-Glutamyl Transferase)
19612,Schizophrenia X Sex Interaction,Phenotype,Schizophrenia X Sex Interaction
19614,Aparc-A2009S Lh Area S-Intrapariet+P-Trans,Phenotype,Aparc-A2009S Lh Area S-Intrapariet+P-Trans
19616,Schizophrenia Or Er Positive Breast Cancer (Pleiotropy),Phenotype,Schizophrenia Or Er Positive Breast Cancer (Pleiotropy)
19619,Axin1/Clip2 Protein Level Ratio,Phenotype,Axin1/Clip2 Protein Level Ratio
19627,Phospholipid Levels In Hdl,Phenotype,Phospholipid Levels In Hdl
19631,Western Dietary Pattern,Phenotype,Western Dietary Pattern
19635,Fibrinogen Levels Or Factor Vii Levels Or Factor Xi Levels Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Fibrinogen Levels Or Factor Vii Levels Or Factor Xi Levels Or Tissue Plasminogen Activator Levels (Pleiotropy)
19639,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy)
19641,Descending Aorta Minimum Area,Phenotype,Descending Aorta Minimum Area
19644,Free Cholesterol To Total Lipids Ratio In Very Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Very Large Vldl
19647,3-(4-Hydroxyphenyl)Lactate Levels,Phenotype,3-(4-Hydroxyphenyl)Lactate Levels
19650,Circulating Leptin Levels,Phenotype,Circulating Leptin Levels
19654,Serum 25-Hydroxyvitamin D Levels (Conditioned On Bmi),Phenotype,Serum 25-Hydroxyvitamin D Levels (Conditioned On Bmi)
19657,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ Levels,Phenotype,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ Levels
19660,Total Lipids In Large Vldl (Ukb Data Field 23496),Phenotype,Total Lipids In Large Vldl (Ukb Data Field 23496)
19662,Alpha-Hydroxyisovalerate Levels,Phenotype,Alpha-Hydroxyisovalerate Levels
19664,Homeostasis Model Assessment Of Insulin Resistance (Dietary Factor Interaction),Phenotype,Homeostasis Model Assessment Of Insulin Resistance (Dietary Factor Interaction)
19666,Snoring,Phenotype,Snoring
19668,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+Nh4]1+ Levels
19670,Total Cholesterol Minus Hdl-C Levels (Ukb Data Field 23401),Phenotype,Total Cholesterol Minus Hdl-C Levels (Ukb Data Field 23401)
19672,Pelvic Organ Prolapse X Maximum Birth Weight Interaction,Phenotype,Pelvic Organ Prolapse X Maximum Birth Weight Interaction
19678,Caffeine Consumption From Tea,Phenotype,Caffeine Consumption From Tea
19680,Urine X-24339 Levels In Chronic Kidney Disease,Phenotype,Urine X-24339 Levels In Chronic Kidney Disease
19682,1-Dihomo-Linolenoyl-Gpe (20:3N3 Or 6) Levels,Phenotype,1-Dihomo-Linolenoyl-Gpe (20:3N3 Or 6) Levels
19692,Serum Levels Of Protein Ccl22,Phenotype,Serum Levels Of Protein Ccl22
19694,Early-Onset Schizophrenia,Phenotype,Early-Onset Schizophrenia
19697,Principal Component-Derived Dietary Pattern 43,Phenotype,Principal Component-Derived Dietary Pattern 43
19701,Iga Nephropathy,Phenotype,Iga Nephropathy
19703,Plasma Anastrozole Concentration In Anastrozole-Treated Estrogen Receptor Positive Breast Cancer,Phenotype,Plasma Anastrozole Concentration In Anastrozole-Treated Estrogen Receptor Positive Breast Cancer
19705,Free Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23647),Phenotype,Free Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23647)
19708,Mean Platelet Volume During The Postpartum Period,Phenotype,Mean Platelet Volume During The Postpartum Period
19711,Serum Levels Of Protein Pomc,Phenotype,Serum Levels Of Protein Pomc
19713,Interleukin-34 Levels,Phenotype,Interleukin-34 Levels
19718,Dipeptidase 2 Levels,Phenotype,Dipeptidase 2 Levels
19722,Abdominal Subcutaneous Adipose Tissue Volume,Phenotype,Abdominal Subcutaneous Adipose Tissue Volume
19724,Alcohol Consumption (Drinks Per Week),Phenotype,Alcohol Consumption (Drinks Per Week)
19731,Glaucoma,Phenotype,Glaucoma
19733,Cocaine Dependence,Phenotype,Cocaine Dependence
19739,Response To Placebo Treatment In Childhood Asthma (Fvc Change),Phenotype,Response To Placebo Treatment In Childhood Asthma (Fvc Change)
19742,Bitter Non-Alcoholic Beverage Consumption,Phenotype,Bitter Non-Alcoholic Beverage Consumption
19744,Attention Deficit Hyperactivity Disorder (Inattention Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Inattention Symptoms)
19747,Glycoprotein Acetyls Levels,Phenotype,Glycoprotein Acetyls Levels
19751,Phosphatidylethanolamine(40:2)_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine(40:2)_[M-H]1- Levels
19753,Node-Level Brain Connectivity (Multivariate Analysis),Phenotype,Node-Level Brain Connectivity (Multivariate Analysis)
19756,Axin1/Itgb1Bp2 Protein Level Ratio,Phenotype,Axin1/Itgb1Bp2 Protein Level Ratio
19759,Subjective Well-Being,Phenotype,Subjective Well-Being
19761,Hair Colour (Natural-- Before Greying): Red (Ukb Data Field 1747_2),Phenotype,Hair Colour (Natural-- Before Greying): Red (Ukb Data Field 1747_2)
19764,Free Cholesterol In Very Small Vldl (Ukb Data Field 23521),Phenotype,Free Cholesterol In Very Small Vldl (Ukb Data Field 23521)
19766,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df),Phenotype,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df)
19771,Total Lipids In Very Large Vldl,Phenotype,Total Lipids In Very Large Vldl
19776,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ Levels
19781,Total Cholesterol Levels (Mtag),Phenotype,Total Cholesterol Levels (Mtag)
19783,Chronic Graft-Versus-Host Disease (Recipient Effect),Phenotype,Chronic Graft-Versus-Host Disease (Recipient Effect)
19786,Breast Dense Area,Phenotype,Breast Dense Area
19789,Cd19 On Unswitched Memory B Cell,Phenotype,Cd19 On Unswitched Memory B Cell
19791,F-Highly Palatable Foods Liking (Derived Food-Liking Factor),Phenotype,F-Highly Palatable Foods Liking (Derived Food-Liking Factor)
19793,Body Mass Index (Age>50),Phenotype,Body Mass Index (Age>50)
19799,Metabolite Levels (Cysteinylglycine Disulfide),Phenotype,Metabolite Levels (Cysteinylglycine Disulfide)
19801,Mannitol/Sorbitol Levels,Phenotype,Mannitol/Sorbitol Levels
19803,Phospholipids In Large Vldl (Ukb Data Field 23497),Phenotype,Phospholipids In Large Vldl (Ukb Data Field 23497)
19806,Red Blood Cell Traits,Phenotype,Red Blood Cell Traits
19810,Vaginal Microbiome Metacyc Pathway (Pwy-5121|Superpathway Of Geranylgeranyl Diphosphate Biosynthesis Ii (Via Mep)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5121|Superpathway Of Geranylgeranyl Diphosphate Biosynthesis Ii (Via Mep))
19812,Cd64 On Cd14+ Cd16+ Monocyte,Phenotype,Cd64 On Cd14+ Cd16+ Monocyte
19821,Testicular Germ Cell Tumor,Phenotype,Testicular Germ Cell Tumor
19824,Body Fat Distribution (Arm Fat Ratio),Phenotype,Body Fat Distribution (Arm Fat Ratio)
19828,Testosterone Levels,Phenotype,Testosterone Levels
19831,T-Cell Receptor Clonality In Colorectal Cancer,Phenotype,T-Cell Receptor Clonality In Colorectal Cancer
19833,C-Type Lectin Domain Family 2 Member D Levels (Clec2D.7054.87.3),Phenotype,C-Type Lectin Domain Family 2 Member D Levels (Clec2D.7054.87.3)
19834,Myopia (Pathological),Phenotype,Myopia (Pathological)
19837,Emphysema Annual Change Measurement In Smokers (Percent Low Attenuation Area),Phenotype,Emphysema Annual Change Measurement In Smokers (Percent Low Attenuation Area)
19839,Aurora Kinase B Levels (Aurkb.3346.72.2),Phenotype,Aurora Kinase B Levels (Aurkb.3346.72.2)
19841,25-Hydroxyvitamin D Levels (Skin Colour Stratified),Phenotype,25-Hydroxyvitamin D Levels (Skin Colour Stratified)
19843,Reaction Time,Phenotype,Reaction Time
19848,Systemic Lupus Erythematosus And Systemic Sclerosis,Phenotype,Systemic Lupus Erythematosus And Systemic Sclerosis
19853,Globulin Levels,Phenotype,Globulin Levels
19858,Mgmt Methylation In Smokers,Phenotype,Mgmt Methylation In Smokers
19860,Non-Glioblastoma Glioma,Phenotype,Non-Glioblastoma Glioma
19865,T1 Freesurfer Pial Rh Supramarginal Area,Phenotype,T1 Freesurfer Pial Rh Supramarginal Area
19868,Unilateral Cleft Lip And Palate,Phenotype,Unilateral Cleft Lip And Palate
19870,Colonoscopy-Negative Controls Vs Population Controls,Phenotype,Colonoscopy-Negative Controls Vs Population Controls
19872,Alzheimer'S Disease (Late Onset),Phenotype,Alzheimer'S Disease (Late Onset)
19874,Free Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Hdl
19877,Serum Levels Of Protein Stx8,Phenotype,Serum Levels Of Protein Stx8
19879,Col1A1/Omd Protein Level Ratio,Phenotype,Col1A1/Omd Protein Level Ratio
19880,Nicotine Dependence And Major Depression (Severity Of Comorbidity),Phenotype,Nicotine Dependence And Major Depression (Severity Of Comorbidity)
19883,Neurofibrillary Tangles,Phenotype,Neurofibrillary Tangles
19887,Free Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23602),Phenotype,Free Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23602)
19889,Ahsp/Blvrb Protein Level Ratio,Phenotype,Ahsp/Blvrb Protein Level Ratio
19893,Feeling Worry,Phenotype,Feeling Worry
19896,Uterine Fibroids And Heavy Menstrual Bleeding,Phenotype,Uterine Fibroids And Heavy Menstrual Bleeding
19898,Alcohol Consumption X Playing Computer Games Interaction,Phenotype,Alcohol Consumption X Playing Computer Games Interaction
19900,Blood Protein Levels In Cardiovascular Risk,Phenotype,Blood Protein Levels In Cardiovascular Risk
19902,Serum Vanadium Levels,Phenotype,Serum Vanadium Levels
19906,Idp Dmri Tbss L1 Uncinate Fasciculus L,Phenotype,Idp Dmri Tbss L1 Uncinate Fasciculus L
19912,Igd On Igd+ Cd24- B Cell,Phenotype,Igd On Igd+ Cd24- B Cell
19914,Hmbs/Pklr Protein Level Ratio,Phenotype,Hmbs/Pklr Protein Level Ratio
19916,Red Vs. Brown/Black Hair Color,Phenotype,Red Vs. Brown/Black Hair Color
19918,Phospholipids In Very Small Vldl (Ukb Data Field 23518),Phenotype,Phospholipids In Very Small Vldl (Ukb Data Field 23518)
19921,Serum Levels Of Protein St14,Phenotype,Serum Levels Of Protein St14
19924,Platelet Forward Scatter Distribution Width,Phenotype,Platelet Forward Scatter Distribution Width
19928,Regional Cortical Thickness (Paracentral),Phenotype,Regional Cortical Thickness (Paracentral)
19931,Total Phospholipid Levels In Lipoprotein Particles,Phenotype,Total Phospholipid Levels In Lipoprotein Particles
19932,Matrix Metalloproteinase-9 Levels,Phenotype,Matrix Metalloproteinase-9 Levels
19934,Severe Malaria,Phenotype,Severe Malaria
19937,Testasv_20 (Phascolarctobacterium) Prevalence,Phenotype,Testasv_20 (Phascolarctobacterium) Prevalence
19941,Tb-Lm Or Tblh-Bmd (Pleiotropy),Phenotype,Tb-Lm Or Tblh-Bmd (Pleiotropy)
19947,Serum Levels Of Protein Gp1Ba,Phenotype,Serum Levels Of Protein Gp1Ba
19949,Pyridoxate Levels In Elite Athletes,Phenotype,Pyridoxate Levels In Elite Athletes
19960,Gestational Length In Nulliparas,Phenotype,Gestational Length In Nulliparas
19963,Regional Cortical Thickness (Parstriangularis),Phenotype,Regional Cortical Thickness (Parstriangularis)
19968,C-C Motif Chemokine 8 Levels,Phenotype,C-C Motif Chemokine 8 Levels
19971,Vaginal Microbiome Relative Abundance (F_Mycoplasmataceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Mycoplasmataceae)
19974,Anxiety,Phenotype,Anxiety
19976,Valine Levels,Phenotype,Valine Levels
19979,Triglycerides To Total Lipids In Small Vldl Percentage (Ukb Data Field 23603),Phenotype,Triglycerides To Total Lipids In Small Vldl Percentage (Ukb Data Field 23603)
19982,Serum Levels Of Protein Ercc4,Phenotype,Serum Levels Of Protein Ercc4
19986,Ovarian Cancer,Phenotype,Ovarian Cancer
19989,Sulfasalazine-Induced Agranulocytosis,Phenotype,Sulfasalazine-Induced Agranulocytosis
19991,Mosaic Loss Of Chromosome X,Phenotype,Mosaic Loss Of Chromosome X
19992,Myopia (Age Of Diagnosis),Phenotype,Myopia (Age Of Diagnosis)
19995,Dna Methylation Phenoage Acceleration,Phenotype,Dna Methylation Phenoage Acceleration
19997,Triglycerides To Total Lipids Ratio In Idl,Phenotype,Triglycerides To Total Lipids Ratio In Idl
19999,Serum Levels Of Protein Azgp1,Phenotype,Serum Levels Of Protein Azgp1
20000,Serum Levels Of Protein Ifna2,Phenotype,Serum Levels Of Protein Ifna2
20001,Serum Levels Of Protein Uts2,Phenotype,Serum Levels Of Protein Uts2
20011,Retinal Vascular Fractal Dimension,Phenotype,Retinal Vascular Fractal Dimension
20023,Pr Interval In Tripanosoma Cruzi Seropositivity,Phenotype,Pr Interval In Tripanosoma Cruzi Seropositivity
20028,Asthma-Chronic Obstructive  Pulmonary Disease Overlap Syndrome,Phenotype,Asthma-Chronic Obstructive  Pulmonary Disease Overlap Syndrome
20031,Decaffeinated Coffee Consumption And/Or Insomnia,Phenotype,Decaffeinated Coffee Consumption And/Or Insomnia
20033,Depressive Symptoms X Stressful Life Events Interaction (2Df Test),Phenotype,Depressive Symptoms X Stressful Life Events Interaction (2Df Test)
20036,Subjective Well-Being (Mtag),Phenotype,Subjective Well-Being (Mtag)
20038,Free Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23632),Phenotype,Free Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23632)
20042,Calsequestrin-2 Levels,Phenotype,Calsequestrin-2 Levels
20046,Clostridioides Difficle Infection,Phenotype,Clostridioides Difficle Infection
20048,Rate Of Cognitive Decline In Alzheimer'S Disease,Phenotype,Rate Of Cognitive Decline In Alzheimer'S Disease
20052,Height (Weighted Gwa),Phenotype,Height (Weighted Gwa)
20056,Diabetic Retinopathy,Phenotype,Diabetic Retinopathy
20060,Waist Circumference,Phenotype,Waist Circumference
20066,Leg Fat Mass And Leg Lean Mass (Pleiotropy),Phenotype,Leg Fat Mass And Leg Lean Mass (Pleiotropy)
20068,Otu99_558 (Bacteroidales) Prevalence,Phenotype,Otu99_558 (Bacteroidales) Prevalence
20071,Sucrose Liking,Phenotype,Sucrose Liking
20073,Sitting Height Ratio,Phenotype,Sitting Height Ratio
20075,Phospholipids In Large Hdl,Phenotype,Phospholipids In Large Hdl
20076,Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23620),Phenotype,Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23620)
20077,Response To Exercise (Triglyceride Level Interaction),Phenotype,Response To Exercise (Triglyceride Level Interaction)
20082,Linoleic Acid Levels,Phenotype,Linoleic Acid Levels
20085,Ddt Metabolite (Ddt O-P') Levels,Phenotype,Ddt Metabolite (Ddt O-P') Levels
20087,Hydantoin-5-Propionic Acid Levels,Phenotype,Hydantoin-5-Propionic Acid Levels
20089,Response To Abacavir-Containing Treatment In Hiv-1 Infection (Virologic Failure),Phenotype,Response To Abacavir-Containing Treatment In Hiv-1 Infection (Virologic Failure)
20091,Thyroid Peroxidase Antibody Levels In Pregnancy,Phenotype,Thyroid Peroxidase Antibody Levels In Pregnancy
20093,Non-Small Cell Lung Cancer,Phenotype,Non-Small Cell Lung Cancer
20098,Cognitive Performance (Global Cognitive Function) (Longitudinal),Phenotype,Cognitive Performance (Global Cognitive Function) (Longitudinal)
20101,Baseline Memory X Sex Interaction,Phenotype,Baseline Memory X Sex Interaction
20104,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (2Df Test),Phenotype,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (2Df Test)
20107,Large Hdl Particle Concentration,Phenotype,Large Hdl Particle Concentration
20113,Acne Vulgaris,Phenotype,Acne Vulgaris
20115,Depression Severity  X Hours Spent Watching Television Interaction,Phenotype,Depression Severity  X Hours Spent Watching Television Interaction
20117,Parental Longevity (Mother'S Age At Death),Phenotype,Parental Longevity (Mother'S Age At Death)
20121,Cholesteryl Ester Levels In Small Hdl,Phenotype,Cholesteryl Ester Levels In Small Hdl
20126,Taurolithocholate 3-Sulfate Levels In Elite Athletes,Phenotype,Taurolithocholate 3-Sulfate Levels In Elite Athletes
20128,Metabolic Biomarkers (Multivariate Analysis),Phenotype,Metabolic Biomarkers (Multivariate Analysis)
20130,Morningness,Phenotype,Morningness
20132,3-Hydroxypropylmercapturic Acid Levels In Smokers,Phenotype,3-Hydroxypropylmercapturic Acid Levels In Smokers
20139,Adverse Response To Drug,Phenotype,Adverse Response To Drug
20141,Rfmri Connectivity (Ica100 Edge 912),Phenotype,Rfmri Connectivity (Ica100 Edge 912)
20143,Gamma-Glutamyltryptophan Levels In Elite Athletes,Phenotype,Gamma-Glutamyltryptophan Levels In Elite Athletes
20146,Cognitive Function,Phenotype,Cognitive Function
20154,Asthma-Copd Overlap Syndrome,Phenotype,Asthma-Copd Overlap Syndrome
20159,Cognitive Function (Delayed Memory),Phenotype,Cognitive Function (Delayed Memory)
20162,Median Relapse-Independent Longitudinal Age-Related Multiple Sclerosis Severity Score In Relapse-Onset Multiple Sclerosis,Phenotype,Median Relapse-Independent Longitudinal Age-Related Multiple Sclerosis Severity Score In Relapse-Onset Multiple Sclerosis
20164,1-Myristoyl-2-Linoleoyl-Gpc (14:0/18:2) Levels,Phenotype,1-Myristoyl-2-Linoleoyl-Gpc (14:0/18:2) Levels
20167,Total Cholesterol Levels In Large Hdl,Phenotype,Total Cholesterol Levels In Large Hdl
20169,Depressed Affect,Phenotype,Depressed Affect
20171,Rostral Anterior Cingulate Cortex Volume,Phenotype,Rostral Anterior Cingulate Cortex Volume
20174,Hippocampal Volume,Phenotype,Hippocampal Volume
20184,Scarlet Fever,Phenotype,Scarlet Fever
20189,E3 Ubiquitin-Protein Ligase Smurf1 Levels,Phenotype,E3 Ubiquitin-Protein Ligase Smurf1 Levels
20191,Fractional Excretion Of Metabolites In Chronic Kidney Disease,Phenotype,Fractional Excretion Of Metabolites In Chronic Kidney Disease
20193,Corneal Resistance Factor (Mtag),Phenotype,Corneal Resistance Factor (Mtag)
20198,Pork Consumption,Phenotype,Pork Consumption
20203,Human Milk Oligosaccharide Concentration (Fucodisialyllacto-N-Hexaose),Phenotype,Human Milk Oligosaccharide Concentration (Fucodisialyllacto-N-Hexaose)
20204,Alzheimer'S Disease Or Family History Of Alzheimer'S Disease,Phenotype,Alzheimer'S Disease Or Family History Of Alzheimer'S Disease
20206,Sphingomyelin (D18:1/20:0-- D16:1/22:0) Levels,Phenotype,Sphingomyelin (D18:1/20:0-- D16:1/22:0) Levels
20211,Phospholipids To Total Lipids Ratio In Idl,Phenotype,Phospholipids To Total Lipids Ratio In Idl
20216,Postprandial Phospholipid Levels In Very Small Vldl,Phenotype,Postprandial Phospholipid Levels In Very Small Vldl
20220,Cholesteryl Esters To Total Lipids Ratio In Very Small Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Very Small Vldl
20223,Phospholipid Levels In Small Vldl,Phenotype,Phospholipid Levels In Small Vldl
20225,Body Mass Index X Age Interaction,Phenotype,Body Mass Index X Age Interaction
20226,Calcium-Binding Protein 7 Levels,Phenotype,Calcium-Binding Protein 7 Levels
20227,Vitamin D Levels,Phenotype,Vitamin D Levels
20229,Plasma Glycosyl Ceramide (D18:1/20:0-- D16:1/22:0)* Levels In Chronic Kidney Disease,Phenotype,Plasma Glycosyl Ceramide (D18:1/20:0-- D16:1/22:0)* Levels In Chronic Kidney Disease
20234,Amyloid Beta Positivity In Normal Cognition,Phenotype,Amyloid Beta Positivity In Normal Cognition
20235,Ldl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Ldl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
20239,Kallikrein-11 Levels,Phenotype,Kallikrein-11 Levels
20242,Macular Thickness,Phenotype,Macular Thickness
20244,Immature Fraction Of Reticulocytes,Phenotype,Immature Fraction Of Reticulocytes
20247,Smoking Intensity (Cotinine Levels/Cigarettes Per Day),Phenotype,Smoking Intensity (Cotinine Levels/Cigarettes Per Day)
20248,Total Concentration Of 19 Human Milk Oligosaccharides,Phenotype,Total Concentration Of 19 Human Milk Oligosaccharides
20252,14-3-3 Protein Zeta/Delta Levels (Ywhaz.5858.6.5),Phenotype,14-3-3 Protein Zeta/Delta Levels (Ywhaz.5858.6.5)
20254,Corneocyte Area,Phenotype,Corneocyte Area
20256,Cholesteryl Esters In Medium Ldl (Ukb Data Field 23541),Phenotype,Cholesteryl Esters In Medium Ldl (Ukb Data Field 23541)
20260,Hematological And Biochemical Traits,Phenotype,Hematological And Biochemical Traits
20262,Cholesteryl Esters To Total Lipids In Small Vldl Percentage (Ukb Data Field 23601),Phenotype,Cholesteryl Esters To Total Lipids In Small Vldl Percentage (Ukb Data Field 23601)
20265,Brain Imaging,Phenotype,Brain Imaging
20266,Ldl (Standard Gwa),Phenotype,Ldl (Standard Gwa)
20268,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
20270,Covid-19 (Severe Vs Population),Phenotype,Covid-19 (Severe Vs Population)
20274,Kallikrein-7 Levels,Phenotype,Kallikrein-7 Levels
20279,Microtubule-Associated Proteins 1A/1B Light Chain 3 Beta 2 Levels,Phenotype,Microtubule-Associated Proteins 1A/1B Light Chain 3 Beta 2 Levels
20287,Apolipoprotein E (Isoform E2) Levels,Phenotype,Apolipoprotein E (Isoform E2) Levels
20290,Cd209 Antigen (Analyte X22576.1) Levels,Phenotype,Cd209 Antigen (Analyte X22576.1) Levels
20292,Tyrosine-Protein Kinase Lck Levels (Lck.4560.34.2),Phenotype,Tyrosine-Protein Kinase Lck Levels (Lck.4560.34.2)
20303,Myeloid Cell Surface Antigen Cd33 Levels,Phenotype,Myeloid Cell Surface Antigen Cd33 Levels
20305,Serum Levels Of Protein Ywhaq,Phenotype,Serum Levels Of Protein Ywhaq
20308,Resistin Levels,Phenotype,Resistin Levels
20311,Total Bilirubin Levels,Phenotype,Total Bilirubin Levels
20313,Phospholipids To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23594),Phenotype,Phospholipids To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23594)
20314,Hepatic Lipid Content In Extreme Obesity,Phenotype,Hepatic Lipid Content In Extreme Obesity
20316,Oleoyl Leucine Levels,Phenotype,Oleoyl Leucine Levels
20319,Phosphatidylcholine (36:0) Levels,Phenotype,Phosphatidylcholine (36:0) Levels
20321,Triglyceride Levels In Vldl,Phenotype,Triglyceride Levels In Vldl
20324,Ldl Cholesterol Levels (Ukb Data Field 23405),Phenotype,Ldl Cholesterol Levels (Ukb Data Field 23405)
20328,Alzheimer'S Disease In Hypertension,Phenotype,Alzheimer'S Disease In Hypertension
20329,Phosphatidylinositol (16:0_20:3) (A) Levels,Phenotype,Phosphatidylinositol (16:0_20:3) (A) Levels
20331,X-16654 Levels,Phenotype,X-16654 Levels
20333,Total Lipids In Idl,Phenotype,Total Lipids In Idl
20338,Uric Acid Clearance,Phenotype,Uric Acid Clearance
20340,Cholesteryl Esters To Total Lipids Ratio In Small Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Ldl
20344,Triglyceride Levels In Large Vldl,Phenotype,Triglyceride Levels In Large Vldl
20347,Lithostathine-1-Alpha Levels,Phenotype,Lithostathine-1-Alpha Levels
20350,Bladder Cancer,Phenotype,Bladder Cancer
20352,Free Cholesterol Levels In Small Vldl,Phenotype,Free Cholesterol Levels In Small Vldl
20355,Lutropin Subunit Beta Levels,Phenotype,Lutropin Subunit Beta Levels
20362,Opioid Analgesic Dose Requirement In Cancer Pain Treatment,Phenotype,Opioid Analgesic Dose Requirement In Cancer Pain Treatment
20367,Duodenal Ulcer,Phenotype,Duodenal Ulcer
20371,Neuritic Plaque,Phenotype,Neuritic Plaque
20374,Ldlr/Pcsk9 Protein Level Ratio,Phenotype,Ldlr/Pcsk9 Protein Level Ratio
20377,Sulfate Levels,Phenotype,Sulfate Levels
20380,Uromodulin Level In Chronic Kidney Disease With Hypertension And No Diabetes (9451_20),Phenotype,Uromodulin Level In Chronic Kidney Disease With Hypertension And No Diabetes (9451_20)
20387,Fms-Related Tyrosine Kinase 3 Ligand Levels,Phenotype,Fms-Related Tyrosine Kinase 3 Ligand Levels
20390,Prostate-Specific Antigen Levels (Conditioned On Lead Snps),Phenotype,Prostate-Specific Antigen Levels (Conditioned On Lead Snps)
20392,Cerebral Amyloid Deposition (Pet Imaging),Phenotype,Cerebral Amyloid Deposition (Pet Imaging)
20394,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [2] Levels,Phenotype,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [2] Levels
20395,Ceramide (D18:2/20:0) Levels,Phenotype,Ceramide (D18:2/20:0) Levels
20397,Ceramide (D19:1/26:0) Levels,Phenotype,Ceramide (D19:1/26:0) Levels
20399,Fasting Total Cholesterol In Very Large Hdl,Phenotype,Fasting Total Cholesterol In Very Large Hdl
20402,Whole Brain Restricted Directional Diffusion (Multivariate Analysis),Phenotype,Whole Brain Restricted Directional Diffusion (Multivariate Analysis)
20404,Spontaneous Preterm Birth (Maternal Effect),Phenotype,Spontaneous Preterm Birth (Maternal Effect)
20406,Balding Type 1,Phenotype,Balding Type 1
20408,Fasting Very Large Hdl Particle Concentration,Phenotype,Fasting Very Large Hdl Particle Concentration
20410,Triglyceride Levels In Current Drinkers,Phenotype,Triglyceride Levels In Current Drinkers
20413,Total Lipids In Small Ldl (Ukb Data Field 23545),Phenotype,Total Lipids In Small Ldl (Ukb Data Field 23545)
20417,Waist-To-Hip Ratio Adjusted For Bmi (Age >50),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Age >50)
20423,Triglycerides To Total Lipids In Large Hdl Percentage (Ukb Data Field 23638),Phenotype,Triglycerides To Total Lipids In Large Hdl Percentage (Ukb Data Field 23638)
20425,Ceramide (D18:1/26:0) Levels,Phenotype,Ceramide (D18:1/26:0) Levels
20428,Sphingomyelin(41:2)_[M+H]1+ Levels,Phenotype,Sphingomyelin(41:2)_[M+H]1+ Levels
20432,Putamen Volume,Phenotype,Putamen Volume
20436,Blood Sugar Levels,Phenotype,Blood Sugar Levels
20438,Concentration Of Vldl Particles,Phenotype,Concentration Of Vldl Particles
20446,Ceramide (D20:1/24:1) Levels,Phenotype,Ceramide (D20:1/24:1) Levels
20449,Measles,Phenotype,Measles
20452,Sphingomyelin (D18:0/20:0-- D16:0/22:0) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:0/20:0-- D16:0/22:0) Levels In Elite Athletes
20458,Ceramide(40:0)_[M-H]1- Levels,Phenotype,Ceramide(40:0)_[M-H]1- Levels
20460,Sphingomyelin(37:1)_[M-Ch3]1- Levels,Phenotype,Sphingomyelin(37:1)_[M-Ch3]1- Levels
20463,Information Processing Speed,Phenotype,Information Processing Speed
20465,Sphingomyelin(37:1)_[M+H]1+ Levels,Phenotype,Sphingomyelin(37:1)_[M+H]1+ Levels
20468,Fasting Insulin,Phenotype,Fasting Insulin
20472,Cobalt Levels,Phenotype,Cobalt Levels
20480,Phospholipid Levels In Small Hdl,Phenotype,Phospholipid Levels In Small Hdl
20485,Retinal Nerve Fibre Layer (Rnfl) Thickness,Phenotype,Retinal Nerve Fibre Layer (Rnfl) Thickness
20488,Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis,Phenotype,Anti-Thyroglobulin (Tgab) Levels In Hashimoto'S Thyroiditis
20490,Idp Dmri Tbss L2 Superior Cerebellar Peduncle L,Phenotype,Idp Dmri Tbss L2 Superior Cerebellar Peduncle L
20492,Sphingomyelin(39:1)_[M+H]1+ Levels,Phenotype,Sphingomyelin(39:1)_[M+H]1+ Levels
20494,Cpxm1/Hbegf Protein Level Ratio,Phenotype,Cpxm1/Hbegf Protein Level Ratio
20496,Subcortical Volume (Min-P),Phenotype,Subcortical Volume (Min-P)
20501,Cystatin-C Levels,Phenotype,Cystatin-C Levels
20504,Heptachlor Epoxide Levels,Phenotype,Heptachlor Epoxide Levels
20509,Matrilin-4 Levels,Phenotype,Matrilin-4 Levels
20513,Waist-To-Hip Ratio Adjusted For Bmi (Age <50),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Age <50)
20515,Age At First Birth,Phenotype,Age At First Birth
20517,Ribavirin-Induced Anemia In Chronic Hepatitis C,Phenotype,Ribavirin-Induced Anemia In Chronic Hepatitis C
20525,Erosive Tooth Wear (Severe Vs Non-Severe),Phenotype,Erosive Tooth Wear (Severe Vs Non-Severe)
20531,Sphingomyelin (D43:1) Levels,Phenotype,Sphingomyelin (D43:1) Levels
20535,Placental Weight (Fetal Genotype-- Adjusted For Sex And Gestational Age),Phenotype,Placental Weight (Fetal Genotype-- Adjusted For Sex And Gestational Age)
20539,Cleft Lip (With Or Without Cleft Palate) Or Cleft Palate,Phenotype,Cleft Lip (With Or Without Cleft Palate) Or Cleft Palate
20545,Vaginal Microbiome Presence (C_Actinobacteria),Phenotype,Vaginal Microbiome Presence (C_Actinobacteria)
20549,Free Cholesterol In Medium Vldl,Phenotype,Free Cholesterol In Medium Vldl
20552,Cerebrospinal Ab1-42 Levels In Normal Cognition,Phenotype,Cerebrospinal Ab1-42 Levels In Normal Cognition
20554,Cholesteryl Esters In Very Large Vldl (Ukb Data Field 23492),Phenotype,Cholesteryl Esters In Very Large Vldl (Ukb Data Field 23492)
20556,Platelet Side Scatter Distribution Width,Phenotype,Platelet Side Scatter Distribution Width
20561,Intraocular Pressure,Phenotype,Intraocular Pressure
20564,Sphingomyelin (D38:0) Levels,Phenotype,Sphingomyelin (D38:0) Levels
20569,F-Chocolate/Coffee Liking (Derived Food-Liking Factor),Phenotype,F-Chocolate/Coffee Liking (Derived Food-Liking Factor)
20577,Triglyceride Levels In Non-Type 2 Diabetes,Phenotype,Triglyceride Levels In Non-Type 2 Diabetes
20580,Nsfl1C/Rwdd1 Protein Level Ratio,Phenotype,Nsfl1C/Rwdd1 Protein Level Ratio
20591,Cholesterol Levels X Vegetarianism Interaction,Phenotype,Cholesterol Levels X Vegetarianism Interaction
20607,Cyclothymic Temperament,Phenotype,Cyclothymic Temperament
20617,Ccn2/Dkk1 Protein Level Ratio,Phenotype,Ccn2/Dkk1 Protein Level Ratio
20619,Chronic Kidney Disease,Phenotype,Chronic Kidney Disease
20621,Covid-19 (Severe Vs Population) X Sex Interaction (Joint Test),Phenotype,Covid-19 (Severe Vs Population) X Sex Interaction (Joint Test)
20623,Neurocognitive Measure (Immediate Recall) In Obsessive-Compulsive Disorder,Phenotype,Neurocognitive Measure (Immediate Recall) In Obsessive-Compulsive Disorder
20629,Daytime Sleep Phenotypes,Phenotype,Daytime Sleep Phenotypes
20633,Ankylosing Spondylitis,Phenotype,Ankylosing Spondylitis
20638,L1-L4 Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,L1-L4 Bone Mineral Density X Serum Urate Levels Interaction
20652,Spontaneous Preterm Birth Without Premature Rupture Of Membranes,Phenotype,Spontaneous Preterm Birth Without Premature Rupture Of Membranes
20655,Catechol Sulfate Levels In Elite Athletes,Phenotype,Catechol Sulfate Levels In Elite Athletes
20662,R-6-Hydroxywarfarin Levels,Phenotype,R-6-Hydroxywarfarin Levels
20670,Externalizing Behaviour (Multivariate Analysis),Phenotype,Externalizing Behaviour (Multivariate Analysis)
20673,Plasma Betaine Levels In Chronic Kidney Disease,Phenotype,Plasma Betaine Levels In Chronic Kidney Disease
20677,Takayasu Arteritis,Phenotype,Takayasu Arteritis
20681,Vaginal Microbiome Metacyc Pathway (Pwy-7234|Inosine-5'-Phosphate Biosynthesis Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7234|Inosine-5'-Phosphate Biosynthesis Iii)
20684,Monocyte Side Scatter,Phenotype,Monocyte Side Scatter
20693,Covid-19 Death (Death Vs Tested And Survived),Phenotype,Covid-19 Death (Death Vs Tested And Survived)
20695,Interferon Alpha/Beta Receptor 1 (Analyte X9183.7) Levels,Phenotype,Interferon Alpha/Beta Receptor 1 (Analyte X9183.7) Levels
20697,Serum 25-Hydroxyvitamin D Levels,Phenotype,Serum 25-Hydroxyvitamin D Levels
20705,Collagen Alpha-2(Vi) Chain Levels,Phenotype,Collagen Alpha-2(Vi) Chain Levels
20707,Hearing Aid Use,Phenotype,Hearing Aid Use
20712,Isthmus-Cingulate Cortex Volume,Phenotype,Isthmus-Cingulate Cortex Volume
20714,Maximum Habitual Alcohol Consumption,Phenotype,Maximum Habitual Alcohol Consumption
20716,Dll1/Nbl1 Protein Level Ratio,Phenotype,Dll1/Nbl1 Protein Level Ratio
20719,Trefoil Factor 1 Levels,Phenotype,Trefoil Factor 1 Levels
20724,Osteoarthritis (Self-Reported),Phenotype,Osteoarthritis (Self-Reported)
20726,Ccn3/Col6A3 Protein Level Ratio,Phenotype,Ccn3/Col6A3 Protein Level Ratio
20728,Metabolonic Lactone Sulfate Levels,Phenotype,Metabolonic Lactone Sulfate Levels
20731,Allergic Disease,Phenotype,Allergic Disease
20736,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (2Df),Phenotype,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (2Df)
20739,Inflammatory Skin Disease,Phenotype,Inflammatory Skin Disease
20742,Triamcinolone Acetonide-Induced Ocular Hypertension,Phenotype,Triamcinolone Acetonide-Induced Ocular Hypertension
20745,Never Eat Eggs Vs No Eggs Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Eggs Vs No Eggs Restrictions (Ukb Data Field 6144)
20747,Transforming Growth Factor Beta Receptor Type 3 Levels,Phenotype,Transforming Growth Factor Beta Receptor Type 3 Levels
20749,Anorectal Malformation,Phenotype,Anorectal Malformation
20753,Depressive Symptoms (Mtag),Phenotype,Depressive Symptoms (Mtag)
20756,Cirrhosis,Phenotype,Cirrhosis
20759,5--6-Dihydrothymine Levels,Phenotype,5--6-Dihydrothymine Levels
20761,Nonalcoholic Fatty Liver Disease (Imputed),Phenotype,Nonalcoholic Fatty Liver Disease (Imputed)
20768,Forns Index In High Alcohol Intake,Phenotype,Forns Index In High Alcohol Intake
20770,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels In Elite Athletes,Phenotype,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels In Elite Athletes
20772,Apom/Mcam Protein Level Ratio,Phenotype,Apom/Mcam Protein Level Ratio
20776,Esophageal Squamous Cell Carcinoma,Phenotype,Esophageal Squamous Cell Carcinoma
20778,Trihexosylcermide (D18:1/22:0) Levels,Phenotype,Trihexosylcermide (D18:1/22:0) Levels
20780,N-Trimethyl 5-Aminovalerate Levels In Elite Athletes,Phenotype,N-Trimethyl 5-Aminovalerate Levels In Elite Athletes
20783,Spherical Equivalent,Phenotype,Spherical Equivalent
20786,Igg Digalactosylation Phenotypes (Multivariate Analysis),Phenotype,Igg Digalactosylation Phenotypes (Multivariate Analysis)
20787,Minimum Measurement Of Hepatic Fat,Phenotype,Minimum Measurement Of Hepatic Fat
20789,Urate Levels In Lean Individuals,Phenotype,Urate Levels In Lean Individuals
20791,Baff-R On Switched Memory B Cell,Phenotype,Baff-R On Switched Memory B Cell
20794,Idp Dmri Tbss L3 Sagittal Stratum R,Phenotype,Idp Dmri Tbss L3 Sagittal Stratum R
20796,Resting State Functional Connectivity Between Dorsal Anterior Insula And Left Putamen,Phenotype,Resting State Functional Connectivity Between Dorsal Anterior Insula And Left Putamen
20799,Bipolar Disorder (Body Mass Index Interaction),Phenotype,Bipolar Disorder (Body Mass Index Interaction)
20801,Gamma-Glutamyltryptophan Levels,Phenotype,Gamma-Glutamyltryptophan Levels
20804,Nicotine Withdrawal,Phenotype,Nicotine Withdrawal
20808,Neuronal Pentraxin Receptor Levels,Phenotype,Neuronal Pentraxin Receptor Levels
20816,Triacylglycerol(56:6)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(56:6)_[M+Nh4]1+ Levels
20823,Seropositivity For Staphylococcus Aureus Peptide (Twist_2995),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_2995)
20828,N-Acetylputrescine Levels,Phenotype,N-Acetylputrescine Levels
20830,Arylsulfatase A Levels,Phenotype,Arylsulfatase A Levels
20832,Btn2A1/Pik3Ip1 Protein Level Ratio,Phenotype,Btn2A1/Pik3Ip1 Protein Level Ratio
20834,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis)
20836,Interleukin-17 Receptor A Levels,Phenotype,Interleukin-17 Receptor A Levels
20838,Spherical Equivalent Or Myopia (Age Of Diagnosis),Phenotype,Spherical Equivalent Or Myopia (Age Of Diagnosis)
20840,Triacylglycerol(56:5)_[M+Nh4]1+ Levels,Phenotype,Triacylglycerol(56:5)_[M+Nh4]1+ Levels
20851,Bin2/Snap29 Protein Level Ratio,Phenotype,Bin2/Snap29 Protein Level Ratio
20854,Wg Lh Intensity-Contrast Superiortemporal,Phenotype,Wg Lh Intensity-Contrast Superiortemporal
20856,Lung Cancer,Phenotype,Lung Cancer
20859,Heschl'S Gyrus Morphology,Phenotype,Heschl'S Gyrus Morphology
20862,Total Trihexosylcermide Levels,Phenotype,Total Trihexosylcermide Levels
20869,Disruptive Behavior (Multivariate Analysis),Phenotype,Disruptive Behavior (Multivariate Analysis)
20871,Mortality In Covid-19,Phenotype,Mortality In Covid-19
20873,Vaginal Microbiome Metacyc Pathway (Pwy-5897|Superpathway Of Menaquinol-11 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5897|Superpathway Of Menaquinol-11 Biosynthesis)
20875,Gamma-Tocopherol/Beta-Tocopherol Levels,Phenotype,Gamma-Tocopherol/Beta-Tocopherol Levels
20880,Contamination Dimension In Obsessive Compulsive Disorder,Phenotype,Contamination Dimension In Obsessive Compulsive Disorder
20886,F-Fish Liking (Derived Food-Liking Factor),Phenotype,F-Fish Liking (Derived Food-Liking Factor)
20888,2-O-Methylascorbic Acid Levels,Phenotype,2-O-Methylascorbic Acid Levels
20891,Impaired Insulin Sensitivity In Response To N-3 Pufa Supplementation,Phenotype,Impaired Insulin Sensitivity In Response To N-3 Pufa Supplementation
20899,Cerebrospinal Fluid 5-Methyluridine (Ribothymidine) Levels,Phenotype,Cerebrospinal Fluid 5-Methyluridine (Ribothymidine) Levels
20904,Idp Dmri Tbss Fa Genu Of Corpus Callosum,Phenotype,Idp Dmri Tbss Fa Genu Of Corpus Callosum
20908,Discordance In Emotional Problems In Monozygotic Twins,Phenotype,Discordance In Emotional Problems In Monozygotic Twins
20911,Testasv_32 (Ruminococcaceae) Abundance,Phenotype,Testasv_32 (Ruminococcaceae) Abundance
20917,Hepcidin Concentration,Phenotype,Hepcidin Concentration
20922,Osteoarthritis (With Total Hip Replacement),Phenotype,Osteoarthritis (With Total Hip Replacement)
20924,Pediatric Non-Alcoholic Fatty Liver Disease Activity Score,Phenotype,Pediatric Non-Alcoholic Fatty Liver Disease Activity Score
20925,Extremely High Intelligence,Phenotype,Extremely High Intelligence
20928,Parental Longevity (Father'S Age At Death),Phenotype,Parental Longevity (Father'S Age At Death)
20932,Ischemic Stroke,Phenotype,Ischemic Stroke
20934,Plasma N-Acetylproline Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylproline Levels In Chronic Kidney Disease
20936,Temporal Pole Thickness (Unadjusted For Global Measures),Phenotype,Temporal Pole Thickness (Unadjusted For Global Measures)
20942,Nevus Count Or Cutaneous Melanoma,Phenotype,Nevus Count Or Cutaneous Melanoma
20945,Smoking Cessation (Mtag),Phenotype,Smoking Cessation (Mtag)
20947,Covid-19 (Severe Vs Tested-- Not Severe),Phenotype,Covid-19 (Severe Vs Tested-- Not Severe)
20953,Otu97_73 (Prevotella) Abundance,Phenotype,Otu97_73 (Prevotella) Abundance
20955,Nonalcoholic Fatty Liver Disease,Phenotype,Nonalcoholic Fatty Liver Disease
20957,Bmi X  Environmental Factors (Excluding Physical Activity) Interaction,Phenotype,Bmi X  Environmental Factors (Excluding Physical Activity) Interaction
20959,Total_GRS,Phenotype,Total_GRS
21229,Lipodystrophy1,Phenotype,Lipodystrophy1
21230,ALPNeg,Phenotype,ALPNeg
21231,Lipodystrophy2,Phenotype,Lipodystrophy2
21232,HyperInsulin,Phenotype,HyperInsulin
21233,BetaCell_2,Phenotype,BetaCell_2
21234,BetaCell_1,Phenotype,BetaCell_1
21235,Apolipoprotein A (Apoa),Phenotype,Apolipoprotein A (Apoa)
21238,alcohol_consumption,Phenotype,alcohol_consumption
21240,Diastolic Blood Pressue,Phenotype,Diastolic Blood Pressue
21246,Systolic Blood Pressue,Phenotype,Systolic Blood Pressue
21249,Pulse Pressure Measurement,Phenotype,Pulse Pressure Measurement
21251,Type 2 Diabetes Mellitus_2024,Phenotype,Type 2 Diabetes Mellitus_2024
21254,Fasting Glucose Hm3,Phenotype,Fasting Glucose Hm3
21260,fibrinogen,Phenotype,fibrinogen
21275,CRP,Phenotype,CRP
21292,Interleukin 1 (Il-1),Phenotype,Interleukin 1 (Il-1)
21297,Fasting Insulin Hm3,Phenotype,Fasting Insulin Hm3
21339,Age,Phenotype,Age
21387,Interleukin 6 (Il-6),Phenotype,Interleukin 6 (Il-6)
21553,Insulin-Like Growth Factor 1 (Igf1),Phenotype,Insulin-Like Growth Factor 1 (Igf1)
21766,Apolipoprotein B (Apob),Phenotype,Apolipoprotein B (Apob)
